Está en la página 1de 153

UNIVERSIDAD POLITÉCNICA DE MADRID

ESCUELA TÉCNICA SUPERIOR DE INGENIEROS EN


TELECOMUNICACIÓN

STUDY OF NEW APPLICATIONS OF THE QUARTZ


CRYSTAL RESONATOR (QCR) FOR THE
CHARACTERIZATION OF VISCOELASTIC
PROPERTIES OF BIOLOGICAL FLUIDS OF INTEREST
FOR MEDICAL APPLICATIONS

PhD THESIS

MSc. Andrés Miranda Martínez

2022
DEPARTAMENTO DE TECNOLOGÍA FOTÓNICA Y BIOINGENIERÍA

ESCUELA TÉCNICA SUPERIOR DE INGENIEROS EN


TELECOMUNICACIÓN

UNIVERSIDAD POLITÉCNICA DE MADRID

STUDY OF NEW APPLICATIONS OF THE QUARTZ


CRYSTAL RESONATOR (QCR) FOR THE
CHARACTERIZATION OF VISCOELASTIC
PROPERTIES OF BIOLOGICAL FLUIDS OF INTEREST
FOR MEDICAL APPLICATIONS

PhD THESIS

Author:

Andrés Miranda Martínez


MSc in Biomedical Engineering

Director:

José Javier Serrano Olmedo


PhD in Telecommunication Engineering

2022
PHD THESIS
STUDY OF NEW APPLICATIONS OF THE QUARTZ
CRYSTAL RESONATOR (QCR) FOR THE
CHARACTERIZATION OF VISCOELASTIC
PROPERTIES OF BIOLOGICAL FLUIDS OF INTEREST
FOR MEDICAL APPLICATIONS

AUTHOR: Andrés Miranda Martínez


DIRECTOR: José Javier Serrano Olmedo

Tribunal nombrado por el Magfco. y Excmo. Sr. Rector de la Universidad


Politécnica de Madrid el día

PRESIDENTE:
SECRETARIO:
VOCAL:
VOCAL:
VOCAL:
SUPLENTE:
SUPLENTE:

i
Realizado el acto de defensa y lectura de tesis el día .

En el Centro de Tecnología Biomédica de la Universidad Politécnica de Madrid.

Calificación:

EL PRESIDENTE: EL SECRETARIO:

__________________________________ __________________________________
D. D.

EL VOCAL: EL VOCAL:

__________________________________ __________________________________
D. D.

EL VOCAL:

__________________________________
D.

ii
LABORATORIO DE BIOINSTRUMENTACIÓN Y
NANOMEDICINA

UNIVERSIDAD POLITÉCNICA DE MADRID

STUDY OF NEW APPLICATIONS OF THE QUARTZ


CRYSTAL RESONATOR (QCR) FOR THE
CHARACTERIZATION OF VISCOELASTIC
PROPERTIES OF BIOLOGICAL FLUIDS OF INTEREST
FOR MEDICAL APPLICATIONS

PhD THESIS

Author:

Andrés Miranda Martínez


MSc in Biomedical Engineering
Director:

José Javier Serrano Olmedo


PhD in Telecommunication Engineering
2022

iii
Agradecimientos

Todo este trabajo tiene detrás a un gran número de personas sin las cuales no

hubiera sido posible su desarrollo. Primero que nada quiero agradecer a Flor,

mi compañera de vida y mi mejor amiga, quien me motiva y me apoya en los

buenos y malos momentos. Este logro se suma a los que ya tenemos y a los que

vendrán.

Agradezco a mi familia, son quienes siempre me apoyaron en mis objetivos y

me alentaron en todo momento. Agradezco a mis padres, quienes me formaron

y a quienes admiro y les debo gran parte de lo que soy hoy en día. Gracias a mi

mamá por su ejemplo y apoyo, mi constancia y responsabilidad se los debo a

ella. Gracias a mi papá por sus enseñanzas y optimismo, de él he aprendido a

disfrutar cada momento de mi vida. Gracias a mi hermana Edith por ser mi

confidente y compañera de travesuras desde pequeños. Siempre estaremos el

uno para el otro.

Agradezco a Antonio, a Flor de María y a Toño, quienes me recibieron con los

brazos abiertos desde el primer día y me han apoyado siempre que lo he

necesitado.

Gracias a todo el grupo del Laboratorio de Bioinstrumentación y Nanomedicina

(LBN), en especial a Michael, mi vecino de escritorio, y con quién compartí la

experiencia del doctorado desde el comienzo y quien fue parte de mi familia en

Madrid. También agradezco a Nazario por sus consejos desde mis comienzos

en la UPM y por su amistad.

Agradezco a Thomas Crouzier y al grupo de Biopolymers for life de KTH (Real

Instituto de Tecnología, Suecia). Mi recibimiento y estancia fueron

iv
extraordinarios. Sus enseñanzas contribuyeron a mi formación como

investigador.

Gracias, por supuesto, a José Javier Serrano Olmedo, investigador principal del

LBN, amigo y director de mi trabajo de fin de máster y de mi tesis doctoral,

quien me ha enseñado y orientado día a día en este mundo de la ingeniería

biomédica y en el mundo de la investigación a lo largo de estos 5 años.

Muchas gracias a los profesores de la UNAM José María Matías, Salvador

Landeros, Víctor García y Jesús Manuel Dorador, por su ejemplo, orientación y

apoyo que me proporcionaron en México para continuar con mi preparación

profesional.

Gracias a los revisores de calidad de la esta tesis y al tribunal por el tiempo que

le han dedicado a este trabajo.

Finalmente, gracias a mis grandes amistades en México, siempre los llevo

presentes.

v
Abstract

Quartz crystal resonators (QCRs) are widely used as sensors because of their

ability to detect changes in the physical properties of the sample placed on their

surface. In addition, they are inexpensive, sensitive, and have good accuracy. Its

small size benefits the use of small sample volumes, which opens the door to

many possible applications in biomedicine and bioengineering.

The UPM ViSQCT project, which is being developed at CTB, has developed a

prototype sensor based on QCRs. This prototype was updated in the present

work. The sensor is based on the analysis of the conductance curve, generated

by exciting the crystal through a frequency sweep (close to the fundamental

resonance frequency of the crystal). The resonance frequency at the maximum

conductance point is its primary reference when evaluating the samples

deposited on its surface.

Two approaches to the application of QCRs as sensors are proposed. First, the

development of the sensor as a valuable tool for diagnosis or classification

between different conditions of the same fluid is sought. An example of this is

the case of synovial fluid. The viscosity of healthy SF decreases in the case of

pathologies such as rheumatoid arthritis or osteoarthritis. Therefore, measuring

the sample's viscosity can be a parameter that helps the classification of the

sample. Otherwise, a larger sample volume would be required, or large and

expensive devices would be used for the same purpose.

A second approach is to use the device as a tool to characterize the formation of

biopolymer-based hydrogels. Such characterization is carried out using

expensive and large equipment. As an alternative, a low-cost, portable and

straightforward system is proposed to assist in this task. Knowledge of the

mechanical properties of these materials is essential, and the design of the

vi
mechanical properties will determine how well the material will perform

depending on its application. When used as scaffolds for cell growth, stiffness is

a determining factor in cell differentiation. If a hydrogel is sought for

bioprinting, a specific viscosity capable of flowing through the nozzle and yet

stable when forming structures will be required. In the case of implantable gels,

their mechanical properties must match the surrounding tissues. With this in

mind, having a device with the described conditions will help researchers

design hydrogels. Therefore, this work proposes the use of this device for two

biomedical applications.

First, measurements were made with synovial fluid and cerebrospinal fluid

phantoms (with contrasting viscoelastic properties), and differences between

healthy and pathological fluids were observed employing the measured

parameters. Subsequently, measurements were made with synovial fluid

provided by the Hospital Universitario La Paz in Madrid. The samples were

previously diagnosed and classified into two groups: inflammatory pathologies

and infectious pathologies. When measuring the samples, using the parameters

obtained for the differentiation of the groups showed low accuracy; however,

when applying artificial neural network algorithms, the accuracy increased.

Finally, experiments were performed with hydrogels to monitor the formation

of the gel by capturing its viscosity change with the sensor. Two types of bonds

were used for gel formation, the first by covalent crosslinking and the second

by physical crosslinking. In addition, for each case, the agents' concentration

varied to vary the physical properties of the resulting gel. The formation of both

types of hydrogels was captured, the sensor having a different response to each

type of concentration.

The proposed technique presents advantages such as simplicity, reduced

sample volume, low cost, and portability, making it accessible to any laboratory

and generating interest in further development.

vii
This thesis provides new contributions to the development of QCR-based

sensors and opens a possibility for further research lines regarding biomedical

applications.

Key words

Sensor, Quartz Crystal Resonators, Quartz Crystal Microbalance, Synovial

Fluid, Biopolymer based Hydrogels.

viii
Resumen

Los resonadores de cristal de cuarzo (QCR) se utilizan ampliamente como

sensores por su capacidad para detectar los cambios en las propiedades físicas

de una muestra colocada en su superficie. Además, son baratos, sensibles y

tienen una buena precisión. Su pequeño tamaño favorece el uso de pequeños

volúmenes de muestra, lo que abre la puerta a muchas posibles aplicaciones en

biomedicina y bioingeniería.

El proyecto ViSQCT de la UPM, que se desarrolla en el CTB, ha desarrollado un

prototipo de sensor basado en QCRs. Este prototipo ha sido actualizado en el

presente trabajo. El sensor se basa en el análisis de la curva de conductancia,

generada al excitar el cristal a través de un barrido de frecuencias (cercano a la

frecuencia de resonancia fundamental del cristal). La frecuencia de resonancia

en el punto de máxima conductancia es su principal referencia a la hora de

evaluar las muestras depositadas en su superficie.

Se proponen dos enfoques para la aplicación de los QCR como sensores. En

primer lugar, se busca el desarrollo del sensor como una valiosa herramienta de

diagnóstico o clasificación entre diferentes condiciones de un mismo fluido. Un

ejemplo de ello es el caso del líquido sinovial. La viscosidad del SF sano

disminuye en el caso de patologías como la artritis reumatoide o la artrosis. Por

lo tanto, la medición de la viscosidad de la muestra puede ser un parámetro que

ayude a la clasificación de la misma. De lo contrario, se necesitaría un mayor

volumen de muestra o se utilizarían dispositivos grandes y caros para el mismo

fin.

Un segundo enfoque es utilizar el dispositivo como herramienta para

caracterizar la formación de hidrogeles basados en biopolímeros. Dicha

caracterización se lleva a cabo utilizando equipos caros y de gran tamaño.

Como alternativa, se propone un sistema de bajo coste, portátil y sencillo para

ix
ayudar en esta tarea. El conocimiento de las propiedades mecánicas de estos

materiales es esencial, y el diseño de las mismas determinará el rendimiento del

material en función de su aplicación. Cuando se utilizan como estructuras para

el crecimiento celular, la rigidez es un factor determinante en la diferenciación

celular. Si se busca un hidrogel para la bioimpresión, se requerirá una

viscosidad específica capaz de fluir a través de la boquilla y a la vez estable al

formar estructuras. En el caso de los geles implantables, sus propiedades

mecánicas deben coincidir con los tejidos circundantes. Teniendo esto en

cuenta, disponer de un dispositivo con las condiciones descritas ayudará a los

investigadores a diseñar hidrogeles. Por ello, este trabajo propone el uso de este

dispositivo para dos aplicaciones biomédicas.

En primer lugar, se realizaron mediciones con fantomas de líquido sinovial y

líquido cefalorraquídeo (con propiedades viscoelásticas contrastadas), y se

observaron diferencias entre los fluidos sanos y patológicos empleando los

parámetros medidos. Posteriormente, se realizaron mediciones con líquido

sinovial proporcionado por el Hospital Universitario La Paz de Madrid. Las

muestras fueron previamente diagnosticadas y clasificadas en dos grupos:

patologías inflamatorias y patologías infecciosas. Al medir las muestras, la

utilización de los parámetros obtenidos para la diferenciación de los grupos

mostró una precisión baja; sin embargo, al aplicar algoritmos de redes

neuronales artificiales, la precisión incrementó considerablemente. Por último,

se realizaron experimentos con hidrogeles para monitorizar la formación del gel

captando su cambio de viscosidad con el sensor. Se utilizaron dos tipos de

enlaces para la formación del gel, el primero por reticulación covalente y el

segundo por reticulación física. Además, en cada caso se varió la concentración

de los agentes para variar las propiedades físicas del gel resultante. Se logró

x
captar la formación de ambos tipos de hidrogeles, teniendo el sensor una

respuesta diferente a cada tipo de concentración.

La técnica propuesta presenta ventajas como la simplicidad, el reducido

volumen de muestra, el bajo coste y la portabilidad, lo que la hace accesible a

cualquier laboratorio y genera interés para su posterior desarrollo. Esta tesis

aporta nuevas contribuciones al desarrollo de sensores basados en QCR y abre

la posibilidad de nuevas líneas de investigación en cuanto a aplicaciones

biomédicas.

Palabras clave

Sensor, Resonadores de Cristal de Cuarzo, Microbalanza de Cristal de cuarzo,

Fluido Sinovial, Hidrogeles basados en Biopolímeros.

xi
Index

Abstract .......................................................................................................................... vi

Resumen ......................................................................................................................... ix

Acronyms ................................................................................................................... xxiv

Nomenclature ............................................................................................................ xxvi

1. Introduction ............................................................................................................ 1

1.1. Reference framework ..................................................................................... 1

1.2. Problem statement .......................................................................................... 2

1.3. Research methodology ................................................................................... 3

1.4. Thesis organization ......................................................................................... 3

2. Theory and State of the Art ................................................................................... 5

2.1. Viscosity ........................................................................................................... 5

2.1.1. Newtonian and non-Newtonian Fluids ............................................... 6

2.2. Human fluids of interest ................................................................................ 7

2.2.1. Synovial Fluid .......................................................................................... 7

2.2.2. Cerebrospinal Fluid ............................................................................... 11

2.2.3. Pleural Effusions .................................................................................... 14

2.3. Biopolymer-based hydrogels ...................................................................... 16

2.3.1. Mucins ..................................................................................................... 17

2.3.2. Alginate ................................................................................................... 17

2.3.3. Biopolymer-based hydrogels in biomedical applications ............... 18

xii
2.4. The importance of the clinical use of viscosity in human fluids ............ 20

2.5. Viscosity measurement techniques ............................................................ 22

2.5.1. Rotational rheometers/viscometers..................................................... 22

2.5.1.1. Concentric cylinders .......................................................................... 23

2.5.1.2. Cone and plate .................................................................................... 24

2.5.1.3. Parallel plate ....................................................................................... 24

2.5.2. Capillary viscometers............................................................................ 25

2.5.3. Falling body method ............................................................................. 26

2.5.4. Ultrasonics .............................................................................................. 27

2.6. Quartz Crystal Resonators ........................................................................... 27

2.6.1. Butterworth-Van Dyke model ............................................................. 29

2.6.2. Mass deposition ..................................................................................... 32

2.6.3. Fluid deposition ..................................................................................... 33

2.6.4. Penetration depth .................................................................................. 34

2.7. QCRs used as viscometers ........................................................................... 35

2.8. Brief description of artificial neural networks .......................................... 35

2.9. ViSQCT project and previous work ........................................................... 37

2.9.1. AD9850 module ..................................................................................... 37

2.9.2. Analog to digital stage .......................................................................... 38

2.9.3. Power supply ......................................................................................... 38

3. Hypothesis and Objectives ................................................................................. 39

3.1. Hypothesis ..................................................................................................... 39

3.2. General and specific objectives ................................................................... 39

xiii
4. Sensor Development ............................................................................................ 41

4.1. Sensor description ......................................................................................... 41

4.2. PCB design ..................................................................................................... 42

4.3. QCRs an holder cell ...................................................................................... 45

4.4. System control and user interface............................................................... 46

4.5. 3D printed case .............................................................................................. 48

4.6. Final prototype .............................................................................................. 49

5. Protocols and Preliminary Measurements ....................................................... 51

5.1. Measurement protocol ................................................................................. 51

5.2. QCR cleaning protocol ................................................................................. 52

5.3. Open QCM ..................................................................................................... 53

5.4. Volume variation with water ...................................................................... 54

5.5. Conventional fluids measurement ............................................................. 55

6. Experimental Methodology ................................................................................ 62

6.1. Phantoms ........................................................................................................ 62

6.1.1. aCSF ......................................................................................................... 63

6.1.2. aSF ............................................................................................................ 64

6.2. Synovial fluid samples ................................................................................. 65

6.3. Biopolymer-based hydrogels samples ....................................................... 65

6.3.1. Covalently crosslinked mucin hydrogels ........................................... 66

6.3.2. Physically crosslinked alginate hydrogels ......................................... 66

7. Results and Discussion ........................................................................................ 67

xiv
7.1. Phantoms ........................................................................................................ 67

7.1.1. aCSF ......................................................................................................... 67

7.1.2. aSF ............................................................................................................ 70

7.2. SF results ........................................................................................................ 74

7.2.1. Inflammatory and infectious SF .......................................................... 74

7.2.2. Comparison between SF pathologies ................................................. 81

7.2.3. Artificial Neural Networks for the classification of inflammatory

and infectious SF .................................................................................................. 83

7.3. Biopolymer-based hydrogels results.......................................................... 88

7.3.1. Covalently crosslinked hydrogels ....................................................... 88

7.3.2. Physically crosslinked alginate hydrogels ......................................... 90

8. Conclusions and Future Work ........................................................................... 96

8.1. Conclusions .................................................................................................... 96

8.2. Future work ................................................................................................... 97

9. Annex ..................................................................................................................... 99

References ................................................................................................................... 109

xv
List of Figures

Figure 1. System for defining viscosity. __________________________________ 6

Figure 2. Viscosity as a function of shear rate for Newtonian and non-

Newtonian Fluids ____________________________________________________ 7

Figure 3: Tetrazine (Tz) and norbornene (Nb) conjugated to BSM and the crosslinking

reaction _____________________________________________________________ 17

Figure 4: Structure of Alginate reacting with 𝐶𝑎2 +and 𝐵𝑎2 +. _____________ 18

Figure 5. Basic structure of concentric cylinders viscometer _______________ 23

Figure 6. Basic structure of cone and plate viscometer ____________________ 24

Figure 7. Basic structure of parallel plates viscometer _____________________ 25

Figure 8. Basic structure of capillary viscometer _________________________ 26

Figure 9. Basic structure of falling body viscometer ______________________ 27

Figure 10. QCR schematic. ____________________________________________ 28

Figure 11. Shear deformation during oscillation in QCR __________________ 28

Figure 12. Butterworth-Van Dyke model of Quartz Crystal Resonators (QCR)

with liquid load. _____________________________________________________ 29

Figure 13. Frequency response of QCR conductance with and without sample.

___________________________________________________________________ 31

Figure 14. QCR admittance locus ______________________________________ 32

Figure 15. Decay depth of the acoustic wave transmitted to the fluid. _______ 35

Figure 16. Basic ANN model.__________________________________________ 36

Figure 17. Simplified diagram of the signals acquisition system. ___________ 38

Figure 18. Excitation and signal acquisition process in the QCR. ___________ 42

xvi
Figure 19. PCB design ________________________________________________ 43

Figure 20. PCB manufactured _________________________________________ 44

Figure 21. Evaluation of the mounted PCB. _____________________________ 44

Figure 22. QCRs used in measurements. ________________________________ 45

Figure 23. Dimensions (in mm) of the QCRs. ____________________________ 45

Figure 24. Design of the lid required for the holder cell. ___________________ 46

Figure 25. Holder cells manufactured in a 3D printer using PLA. ___________ 46

Figure 26. QCR placed in the holder cell.________________________________ 46

Figure 27. Main window. _____________________________________________ 47

Figure 28. Results window. ___________________________________________ 47

Figure 29. Simplified flowchart of the program algorithm. ________________ 48

Figure 30. Design of the lid and the base of the case. ______________________ 49

Figure 31. 3D printed case. ____________________________________________ 49

Figure 32. ViSQCT sensor _____________________________________________ 49

Figure 33. System elements. ___________________________________________ 50

Figure 34. Complete system operating. _________________________________ 50

Figure 35. Signal acquisition method for Open QCM sensor. ______________ 53

Figure 36. Viscosity measured by varying the volume of water samples. ____ 55

Figure 37. ∆𝑓 measured for water, acetone and alcohol. ___________________ 57

Figure 38. Viscosity measured for water, acetone and alcohol. _____________ 57

Figure 39. Comparison of ∆𝑓 measured for glycerin, sugar, and salt using both

sensors. ____________________________________________________________ 59

xvii
Figure 40. Comparison of ∆Γ measured for glycerin, sugar, and salt using

ViSQCT sensor. _____________________________________________________ 59

Figure 41. Comparison of the viscosity obtained using both sensors and the

viscometer (for glycerin, sugar, and salt). _______________________________ 59

Figure 42. Resonance frequency measurement for water and sugar 30% using:

ViSQCT sensor (left) and Open QCM sensor (right). ______________________ 60

Figure 43. Measurements set-up. ______________________________________ 62

Figure 44. Synovial fluid samples. _____________________________________ 65

Figure 45. ∆𝑓 (black line) and ΔΓ (red line) obtained for aCSF samples. _____ 68

Figure 46. Viscosity obtained with the sensor using aCSF. _________________ 69

Figure 47. Adjustment between the viscosity values measured with the sensor

with the viscosity of the rotational viscometer for aCSF samples. ___________ 70

Figure 48. ∆f (black line) and ΔΓ (red line) obtained for aSF samples. _______ 72

Figure 49. Viscosity obtained with the sensor using aSF. __________________ 73

Figure 50. Adjustment between the viscosity values measured with the sensor

with the viscosity of the rotational viscometer for aSF samples. ____________ 73

Figure 51. ∆𝑓 boxplots. Left: EDTA tube; right: Lithium heparin tube _______ 75

Figure 52. ΔΓ boxplots. Left: EDTA tube; right: Lithium heparin tube ______ 75

Figure 53. Viscosity boxplots. Left: EDTA tube; right: Lithium heparin tube _ 75

Figure 54. Boxplots per sample (EDTA tube) for ∆𝑓 measurements. ________ 76

Figure 55. Boxplots per sample (EDTA tube) for ΔΓ measurements. ________ 76

Figure 56. Boxplots per sample (EDTA tube) for viscosity values. __________ 77

Figure 57. Boxplots per sample (Lithium heparin tube) for ∆f measurements. 77

xviii
Figure 58. Boxplots per sample (Lithium heparin tube) for ΔΓ measurements. 78

Figure 59. Boxplots per sample (Lithium heparin tube) for viscosity values. _ 78

Figure 60. ROC curve for parameters measured with the sensor for: SF in EDTA

tubes (left) and SF in lithium heparin tubes (right). _______________________ 81

Figure 61. Comparison between obtained ∆𝑓 for specific SF conditions. _____ 82

Figure 62. Comparison between obtained ΔΓ for specific SF conditions. _____ 82

Figure 63. Comparison between obtained viscosity for specific SF conditions. 82

Figure 64. ANN algorithm for SF classification. __________________________ 84

Figure 65. Confusion matrices obtained by ANN for SF samples contained in

EDTA tubes. ________________________________________________________ 87

Figure 66. Confusion matrices obtained by ANN for SF samples contained in

lithium heparin tubes. ________________________________________________ 88

Figure 67. Time-dependent evaluation of ∆f (black line) and ΔΓ (red line) for 15

mg/ml Muc-gels. ____________________________________________________ 89

Figure 68. Time-dependent evaluation of ∆f (black line) and ΔΓ (red line) for 25

mg/ml Muc-gels. ____________________________________________________ 90

Figure 69. ∆f (black line) and ΔΓ (red line) change after placing an alginate

solution (15 mg/ml) on the sensor. _____________________________________ 91

Figure 70. ∆f (black line) and ΔΓ (red line) change likely caused by a dilution

effect following exposure of the alginate to a solution of NaCl (0.4 M). ______ 91

Figure 71. Comparison of Δf plateau-like stage for the four cases. __________ 92

Figure 72. ∆f (black line) and ΔΓ (red line) response for alginate gel formation

using 𝐵𝑎𝐶𝑙2 (0.4 M). __________________________________________________ 93

Figure 73. ∆f (black line) and ΔΓ (red line) response for alginate gel formation

using 𝐵𝑎𝐶𝑙2 (0.2 M). _________________________________________________ 93

xix
Figure 74. ∆f (black line) and ΔΓ (red line) response for alginate gel formation

using 𝐶𝑎𝐶𝑙2 (0.4 M). _________________________________________________ 93

Figure 75. ∆f (black line) and ΔΓ (red line) response for alginate gel formation

using 𝐶𝑎𝐶𝑙2 (0.2 M). _________________________________________________ 94

Figure 76. Kinetics of the alginate gelation process with all the cases evaluated.

___________________________________________________________________ 95

Figure 77.Variation of accuracy throughout training with one layer and 100

epochs using SF stored in tubes with EDTA. ____________________________ 99

Figure 78. Variation of losses throughout training with one layer and 100

epochs using SF stored in tubes with EDTA. ___________________________ 100

Figure 79. Variation of accuracy throughout training with one layer and 200

epochs using SF stored in tubes with EDTA. ___________________________ 100

Figure 80.Variation of losses throughout training with one layer and 200 epochs

using SF stored in tubes with EDTA. __________________________________ 101

Figure 81. Variation of accuracy throughout training with one layer and 300

epochs using SF stored in tubes with EDTA. ___________________________ 101

Figure 82. Variation of losses throughout training with one layer and 300

epochs using SF stored in tubes with EDTA. ___________________________ 101

Figure 83. Variation of accuracy throughout training with two layers and 100

epochs using SF stored in tubes with EDTA. ___________________________ 102

Figure 84. Variation of losses throughout training with two layers and 100

epochs using SF stored in tubes with EDTA. ___________________________ 102

Figure 85. Variation of accuracy throughout training with two layers and 200

epochs using SF stored in tubes with EDTA. ___________________________ 102

xx
Figure 86. Variation of losses throughout training with two layers and 200

epochs using SF stored in tubes with EDTA. ___________________________ 103

Figure 87. Variation of accuracy throughout training with two layers and 300

epochs using SF stored in tubes with EDTA. ___________________________ 103

Figure 88. Variation of losses throughout training with two layers and 300

epochs using SF stored in tubes with EDTA. ___________________________ 103

Figure 89. Variation of accuracy throughout training with one layer and 100

epochs using SF stored in tubes with lithium heparin. ___________________ 104

Figure 90. Variation of losses throughout training with one layer and 100

epochs using SF stored in tubes with lithium heparin. ___________________ 104

Figure 91. Variation of accuracy throughout training with one layer and 200

epochs using SF stored in tubes with lithium heparin. ___________________ 105

Figure 92. Variation of losses throughout training with one layer and 200

epochs using SF stored in tubes with lithium heparin. ___________________ 105

Figure 93. Variation of accuracy throughout training with one layer and 300

epochs using SF stored in tubes with lithium heparin. ___________________ 105

Figure 94. Variation of losses throughout training with one layer and 300

epochs using SF stored in tubes with lithium heparin. ___________________ 106

Figure 95. Variation of accuracy throughout training with two layers and 100

epochs using SF stored in tubes with lithium heparin. ___________________ 106

Figure 96. Variation of losses throughout training with two layers and 100

epochs using SF stored in tubes with lithium heparin. ___________________ 106

Figure 97. Variation of accuracy throughout training with two layers and 200

epochs using SF stored in tubes with lithium heparin. ___________________ 107

xxi
Figure 98. Variation of losses throughout training with two layers and 200

epochs using SF stored in tubes with lithium heparin. ___________________ 107

Figure 99. Variation of accuracy throughout training with two layers and 300

epochs using SF stored in tubes with lithium heparin. ___________________ 107

Figure 100. Variation of losses throughout training with two layers and 300

epochs using SF stored in tubes with lithium heparin. ___________________ 108

xxii
List of Tables

Table 1. Classification parameters for healthy, non-inflammatory, inflammatory,

septic and hemorrhagic SF. ___________________________________________ 11

Table 2. Composition of normal CSF ___________________________________ 12

Table 3. CSF constituents in different disorders. Obtained from [28] ________ 14

Table 4. Water, acetone and alcohol data and results. _____________________ 56

Table 5. Results for glycerin, sugar and salt. _____________________________ 58

Table 6. Artificial Cerebrospinal Fluids (aCSF) compositions. ______________ 63

Table 7. Artificial Synovial Fluids (aSF) compositions. ____________________ 64

Table 8. aCSF data and results obtained with the sensor. __________________ 67

Table 9. aSF data and results obtained with the sensor. ___________________ 71

Table 10. Mean value and p-value per parameter for each classification and

container type _______________________________________________________ 79

Table 11. Area under the ROC curve of the parameters as predictors for

infectious fluid for both tubes. _________________________________________ 80

Table 12. p-value calculation employing Tukey HSD for specific diseases. ___ 83

Table 13. Accuracy obtained for each test. _______________________________ 85

Table 14. Features of the ANN. ________________________________________ 99

xxiii
Acronyms

aCSF artificial Cerebrospinal Fluid

ANN Artificial Neural Network

aSF artificial Synovial Fluid

BM Bacterial Meningitis

BSM Bovine Submaxillary Mucin

BVD Butterworth-Van Dyke

CPPD Calcium Pyrophosphate Deposition

CSF Cerebrospinal Fluid

CTB Centro de Tecnología Biomédica

DDS Direct Digital Synthesis

ECM Extracellular Matrix

EDTA Ethylenediaminetetraacetic acid

EPEs Exudative Pleural Effusions

GelMA Gelatin-methacryloyl

HA Hyaluronic Acid

LBN Laboratorio de Bioinstrumentación y Nanomedicina

LP Lumbar Puncture

xxiv
Muc Mucines

MUS Monosodium urate

Nb Norbornene

OA Osteoarthritis

PCB Printed Circuit Board

PCR Polymerase chain reaction

QCM Quartz Crystal Microbalance

QCR Quartz Crystal Resonator

RA Rheumatoid Arthritis

SDS Sodium dodecyl sulfate

SF Synovial Fluid

TPEs Transudative Pleural Effusions

Tz Tetrazine

UPM Universidad Politécnica de Madrid

VM Viral Meningitis

WBC White Blood Cells

xxv
Nomenclature

Y Admittance

𝛺 Angular velocity (rad/s)

𝐵𝑎2+ Barium ion

𝐻𝐶𝑂3− Bicarbonate ion

𝐶𝑎2+ Calcium ion

𝐶𝑙 − Chloride ion

G Conductance

𝜌 Density (mg/ml)

D Dissipation

𝑓0 Fundamental resonance frequency

Γ Half-bandwidth at half-maximum

ΔΓ Half-bandwidth at half-maximum shift

n Overtone number

δ Penetration depth

𝐾+ Potassium ion

Q Quality factor

xxvi
𝛥𝑓 Resonance frequency shift

𝑓𝑚 Resonant frequency at the maximum admittance point

𝑓𝑠 Series resonance frequency

𝐺𝑞 Shear modulus of quartz

𝛾̇ Shear rate (1/s)

τ Shear stress (Pa)

𝑁𝑎+ Sodium ion

𝜌𝑞 Specific density of quartz

B Susceptance

𝑑𝑞 Thickness of quartz

T Torque (dyne/cm)

𝜂 Viscosity (Pa·s)

𝑣𝑞 Wave speed of quartz

𝑓𝑟 Zero-phase resonant frequency

xxvii
Chapter 1

1. Introduction

1.1. Reference framework

Quartz Crystal Resonators (QCR) are elements that can be used in various

applications. This is mainly due to the piezoelectric effect they possess, which

was first studied in 1880 by the Curie brothers [1], [2]. Other factors that make

them highly usable are their low cost and high accuracy.

The best-known application is as a gravimetric sensor with the well-known

Quartz Crystal Microbalance (QCM), whose discovery dates back to 1959, given

the research of Günter Sauerbrey [3]. Sauerbrey showed the change of

resonance frequency by depositing tiny masses (nanograms) on the surface of

crystals. Later, in 1985, research by J. G. Gordon and K. K. Kanazawa showed

the effect caused by depositing a fluid on the surface of crystals [4]. Now, the

change of resonance frequency of the crystal would be caused by the product of

the density and viscosity of the deposited liquid. This opened the door to new

lines of research, mainly in the areas of biology, chemistry, and biomedicine.

A few years ago (2015), Diethelm Johannsmann published a book entitled "The

Quartz Crystal Microbalance in Soft Matter Research" [2] in which the use of

crystals in contact with samples such as polymers, cells, proteins, etc., is studied

in depth. This provides an overview of the development of these devices from

their discovery to their current applications.

The use of QCRs in the biomedical field has been growing over the years, with

studies using the crystals to detect specific agents and identify diseases such as

influenza [5]–[7], malaria [7], [8], Human Immunodeficiency Virus (HIV) [7],

[9], tuberculosis [10]–[12], Alzheimer's [13] and breast cancer cells [14]. In

addition, experiments are being conducted in [15] to observe the response of

1
Miranda-Martínez

these sensors when measuring blood, thereby preventing cardiovascular

disease.

Taking into account the broad capabilities of QCRs as sensors, the ViSQCT

project at the Universidad Politécnica de Madrid (UPM) has developed a

functional prototype for fluid characterization using a small sample volume

(tens of microliters) by measuring the physical property of viscosity to broaden

the applications for these devices in the field of bioengineering and

biomedicine. All this is within the Bioinstrumentation and Nanomedicine

Laboratory (LBN) of the Centre for Biomedical Technology (CTB).

1.2. Problem statement

As mentioned above, the use of QCRs as sensors has many advantages. The

possibility of measuring small volumes allows us to explore biomedical cases

where the sample is small. The first case we decided to explore is the distinction

between human fluids, either to differentiate between a healthy and a

pathological fluid or to classify between different conditions of the same fluid.

Otherwise, existing instrumentation is costly, bulky, or incapable of doing so, as

they require a larger sample volume than the existing one.

A second alternative proposed is to characterize the formation of hydrogels.

Monitoring the hydrogel formation process contributes to the hydrogel's design

process, which will define its mechanical properties, which are crucial for its

performance. Like the first case, the existing instrumentation for this type of

analysis is costly and/or bulky.

This work emerges from the need for a sensor that allows the viscosity of a

liquid to be characterized using a small sample volume and whose use is for

biomedical applications. In these cases, the sample volume is usually reduced.

In addition to this development, the aim is to generate an instrument whose

2
Chapter 1

cost and dimensions are reduced, which increases its accessibility in

laboratories.

1.3. Research methodology

The methodology followed in this work corresponds to three stages. The first is

the research and study of the state of the art and theory surrounding the

project, including reviewing current journals that serve as a reference. It is also

essential to know the status of the project to contemplate the knowledge

derived from previous work. From this, the hypothesis and objectives of the

work are set out. The second part considers the planning of future

experimentation and the development of a new version of the device. Finally,

the third stage involves experimentation and analysis of the results obtained.

1.4. Thesis organization

The present work is divided into nine chapters, which will be described below.

The first chapter describes the rationale of the thesis. The research

methodology, the problem to be addressed, and the origin and motivation of

the project are illustrated.

The second chapter brings together state of the art and theoretical concepts

surrounding the work. The fundamental concepts of QCRs, viscosity, and

viscosity measurement methods are explained. It also details the human fluids

of interest for the project, why viscosity measurement is interesting from a

medical point of view, and the application of biopolymer-based hydrogels in

biomedicine. Finally, the project's background, the starting point of the present

work, is discussed.

The third section sets out the hypothesis of the work and the objectives, both

general and specific.

3
Miranda-Martínez

The fourth part begins to talk about the work carried out by describing the

development of the prototype used.

Chapter five mentions the protocols established for the experimental process

and the device's first measurements.

The sixth section develops the experimental methodology and describes the

samples used in the experiments.

The seventh chapter shows the results obtained in each experiment.

Conclusions and proposals for future work are presented in the eighth chapter.

4
Chapter 2

2. Theory and State of the Art

The development of this work begins with the explanation of the concepts that

are parts of it, such as viscosity, quartz crystal crystals, biological fluids of

interest, and viscosity measurement techniques. Subsequently, the focus is

given on why viscosity is a parameter of medical interest and the main

applications of biomaterials such as hydrogels. Finally, examples of advances in

the use of quartz crystal resonators for viscosity measurement are given, and

the context and start of the ViSQCT project in which this work was developed

are introduced.

2.1. Viscosity

Viscosity is a mechanical property of all fluids that can be defined in various

ways, for example, as the fluid's internal friction or the resistance of a fluid to

the movement produced by a force [16]. A couple of parameters, shear stress

and shear rate, must first be defined to describe it adequately in physical terms.

Looking at Figure 1, we have a fluid placed in the middle of two parallel plates

and a force applied to the upper plate, which will cause the displacement of the

fluid layers adjacent to the upper plate in the same direction as the force. The

resulting effect will be a gradient of velocities in the fluid layers as they move

away from the upper plate. Thus, the applied force is the shear stress τ, defined

as a force applied tangentially over an area whose measurement unit is pascals

(Pa); and the resulting strain rate illustrated as the velocity gradient is the shear

rate γ̇ (𝑠 −1 ) [16], [17]. Mathematically, the viscous response of this system

against the shear force is described as:

𝜏 = 𝜂 · γ̇ (1)

where 𝜂 is the coefficient of viscosity, being more specific, considering that a

shear force is being applied, 𝜂 is called the shear dynamic viscosity. In SI units,

5
Miranda-Martínez

𝜂 is measured in pascals per second (Pa·s), and in c.g.s. units, it is measured in

poise (P). Both can be related as follows: 1 cP = 1 mPa·s.

Figure 1. System for defining viscosity.

2.1.1. Newtonian and non-Newtonian Fluids

The viscosity equation expressed in (1) is valid for so-called Newtonian fluids.

The name is given because it was formulated by Sir Isaac Newton. If the fluid's

viscosity is constant regardless of the shear rate, then it is known as a

Newtonian fluid, water being a clear example of this type of fluid. However,

there are a large number of fluids whose viscosity is shear rate dependent.

These types of fluids are called non-Newtonian fluids [16], [17].

Figure 2 shows the viscosity behavior as a function of shear rate for a

Newtonian fluid and two cases of non-Newtonian fluids: Shear Thickening and

Shear Thinning (Pseudoplastic). It is observed that for a Newtonian fluid, the

viscosity will be the same regardless of the shear rate. In the case of fluids with

shear thickening behavior, the viscosity will increase as the shear rate increases.

A typical example of such a fluid is cornstarch. Conversely, a fluid with shear

thinning behavior will have a decreasing viscosity as the shear rate increases.

Examples of this case can be paint and ketchup.

6
Chapter 2

Figure 2. Viscosity as a function of shear rate for Newtonian and non-Newtonian Fluids

2.2. Human fluids of interest

In the context of this work, the analysis of three types of biological fluids whose

viscosity is related to their state of health is proposed. The first is the synovial

fluid which is located in the joints of the body. The second is the cerebrospinal

fluid situated mainly in the brain, and the third is the pleural effusion, an

accumulation of fluid inside the membrane covering the lungs. Synovial fluid

was used for the experimental part; however, the study with cerebrospinal fluid

and pleural effusion are of great interest for future trials.

2.2.1. Synovial Fluid

Synovial Fluid (SF) is a viscous liquid located in the joints whose main

functions are divided into two. The first is the joints' mechanical function,

which consists of lubricating the articular surface and cushioning movements.

The second is to contribute to the nutrition of the articular cartilage by acting as

a nutrient transport medium. It is composed of dialysate of plasma and a high

content of Hyaluronic Acid (HA) [18], [19].

The analysis of this fluid begins with the extraction of the fluid. This process is

called arthrocentesis. The process involves a puncture of the joint to extract the

SF. Then, the sample is collected in a purple-topped tube containing

ethylenediaminetetraacetic acid (EDTA) as an anticoagulant [18], [20].

7
Miranda-Martínez

Usually, SF analysis is composed of four studies [18], [21]:

1. Macroscopic, where the physical characteristics of the fluid such as color,

viscosity, and volume are analyzed.

2. Microscopic, which includes a leukocyte count plus a scan of crystals and

definition by polarized light.

3. Chemical. Protein, glucose, uric acid, lactic acid and rheumatoid factor

levels should be evaluated.

4. The use of differential stains such as Gram stain, Wright, Red Alizarin,

among others.

The volume required depends on the analysis to be performed (and may vary

between laboratories). For example, for an accurate cell count, approximately 1

ml is required; 2 to 3 ml is an adequate volume to perform the required tests. In

case of obtaining a low volume sample, it should be sent for the analysis of

crystals and culture, which are more diagnostic [20].

2.2.1.1. Macroscopic analysis of SF

Regarding volume, the maximum amount that can be obtained from a normal

joint is between 0.1 and 3.5 ml. The knee can have up to 4 ml. If a larger volume

is obtained, it is an indication of an inflammatory process [18], [21], [22].

Healthy synovial fluid is transparent in color and may have light straw-yellow

tones. Its viscosity is similar to egg white and is included in non-Newtonian

fluids with pseudoplastic behavior. To determine the viscosity, it is usual to

observe the stranding, i.e., to measure the "thread" formed by the liquid when

extended. This can be done by placing the sample drop on a slide and lifting it

with a spatula or using the thumb and forefinger to spread it out. For a healthy

fluid, the "thread" may measure between 3 and 6 cm. SF with poor viscosity will

form a "thread" of less than 3 cm [18], [21], [23]. This method is a subjective

8
Chapter 2

form of evaluation and depends on the skills and experience of the operator. It

is possible to use a viscometer or rheometer to measure viscosity; however, they

usually require more sample volume than is available or are expensive and

large to keep within reach.

SF viscosity depends on HA concentration, so at lower concentrations, the

viscosity decreases. Some studies relate the SF’s low viscosity with rheumatic

diseases, such as Rheumatoid Arthritis (RA) and Osteoarthritis (OA) [20], [22],

[24].

An extra test is the mucin clot test, also called the Rope test. This consists of

adding four parts of 2% acetic acid to one part of SF and observing the clot

formation. A clot is categorized as good when it is tight ropy, which correlates

with a normal high viscosity, while a poor clot that breaks easily corresponds to

an inflammatory SF [20].

2.2.1.1. Microscopic analysis of SF

Cell counting should be performed within the first two hours after fluid

extraction, using saline as a diluent in synovial fluids with high cell counts. In

normal SF, the leukocyte count should be less than 200 cells/µl, and in septic SF

the number is greater than 75,000 cells/µl [18], [21].

The differential examination will indicate the percentages of white blood cells.

Normal SF contains few neutrophils and a low number of lymphocytes. The

normal distribution is neutrophils 7%, lymphocytes 24%, monocytes 48%,

macrophages 10%, and synovial lining cells 4% [18].

Crystal identification is performed using a polarized light microscope. With this

study, monosodium urate (MSU) crystals, which are negatively birefringent, are

located. With the help of the polarized light microscope, their thin, needle-like

shape can be precisely observed. The detection of MSU crystals diagnoses gout.

9
Miranda-Martínez

Other crystals commonly found in SF are calcium pyrophosphate dehydrate

(CPPD) [18], [21] which are present in pseudogout cases.

2.2.1.2. Chemical analysis of SF

These studies include the measurement of protein, glucose, uric acid, and

rheumatoid factor levels.

The normal protein level in SF is in the range of 1 - 3 g/dL. A higher level may

be observed in cases of arthritis, arthropathies, and ankylosing spondylitis. Its

evaluation does not determine between inflammatory and non-inflammatory

fluid [18], [23].

SF glucose should be measured from a fasting specimen whose normal levels

are less than 10 mg/ml. Glucose values greater than 50 mg/ml suggest an

infectious process. As for uric acid, in SF, it usually is in the range of 6 to 8

mg/dl. A high value helps in the diagnosis of gout [18], [20].

Another parameter of interest is Rheumatoid Factor (RF), which is an antibody

against immunoglobulins. RF is present in most patients with RA, although it

may be the result of other diseases, which lends itself to false positives [18].

2.2.1.3. Stains

Staining and culturing makes it possible to identify infections in SF samples and

differentiate the type of cells present. Some of these are Gram's stain, Wright's

stain, and alizarin red stain. Gram staining is performed on the SF sample after

centrifugation. It is a relatively inexpensive and straightforward process,

although it depends on the interpretation of the observer. This study can

provide information on the presence of infection and the type of organism

present. Staining with alizarin red helps detect calcium hydroxyapatite crystals

that are not birefringent and, therefore, difficult to detect by microscopy.

10
Chapter 2

Staining with Wright's stain makes it possible to differentiate the cells present in

the sample from the SF [18], [20], [21]. Table 1 summarizes the most important

parameters for classifying SF into healthy, inflammatory, non-inflammatory,

septic, and hemorrhagic. Taken from: [18], [20], [21], [23].

Normal Non- Inflammatory Septic Hemorrhagic


inflammatory

Aspect Transparent Yellow, straw- Yellow, turbid Cloudy, Bloody


straw-colored colored and
turbid and
cloudy opaque

Viscosity High Decreased Low Low Absent-Variable

Mucin clot Good Fair Poor Poor Poor

SF < 200 < 2000 2000-50,000 > 50,000 Variable


WBC*/mm3

Glucose 95 – 100 95 - 100 80 - 100 <50 -

(% blood
level)
Protein 1.3 – 1.8 3.0 - 3.5 > 4.0 > 4.0 -

Crystals None None Multiple or None None


None
Table 1. Classification parameters for healthy, non-inflammatory, inflammatory, septic and
hemorrhagic SF.

*White Blood Cells

2.2.2. Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a clear, colorless fluid produced mainly by the

choroid plexus, whose function is to protect the central nervous system. It

comprises many ions (Na+ , Cl− , 𝐻𝐶𝑂3− , K + , Ca2+ ), vitamins and peptides. In

Table 2, the composition of normal CSF is disaggregated. Its cell count does not

exceed five cells per millimeter [25]–[27]. Adults' average volume of CSF is 150

ml, distributed approximately 25 ml in the ventricles and 125 ml in the cranial

subarachnoid and spinal subarachnoid spaces [25], [26].

11
Miranda-Martínez

Constituent Concentration (mmol/l)

Sodium 138

Potassium 2.8

Calcium 1.1

Chloride 119

Bicarbonate 22

Table 2. Composition of normal CSF

To study the CSF, it is necessary to have access to it through a lumbar puncture

(LP), an invasive procedure in which the restricted compartment of the

subarachnoid space is accessed. LP involves introducing a needle below the

termination of the spinal cord, allowing access to the subarachnoid space.

Depending on the patient and the purpose, between 1 and 20 ml are extracted

[28].

CSF's routine analysis involves microscopic study (white cell count) glucose

and protein testing. For the glucose study, it is important to have a matched

serum glucose sample to be able to make the comparison between serum and

CSF glucose. Depending on the pathology, other tests such as cell culture,

staining and/or polymerase chain reaction (PCR) will be performed [26], [28].

Healthy CSF will have a clear appearance, low cell count (0 - 5 cells/𝑚𝑚3 ), a

protein concentration of approximately 0.5 g/l, and the glucose is between 60-

75% of that measured in serum [26], [28], [29]. Values may vary depending on

the author.

2.2.2.1. Bacterial Meningitis diagnose

Bacterial meningitis (BM) is an infection that occurs when pathogenic virulence

factors overcome host defense mechanisms. The most common bacteria causing

12
Chapter 2

meningitis are S. pneumoniae, Haemophilus influenzae, Neisseria meningitidis,

and Escherichia coli, whose neurotropic potential is related to their ability to

evade host defenses. These types of infections can cross the blood-brain barrier

and survive in the CSF [30], [31].

The gold standard for diagnosing BM is by cell culture. CSF Gram stain, latex

agglutination test, and PCR are other diagnostic tools that can aid in etiologic

diagnosis. Glucose levels (CSF-serum ratio) usually decrease, and proteins

levels increase [29], [32].

Gram staining is an inexpensive and validated diagnostic tool that is used to

identify the causative organism for patients with suspected BM, especially in

cases where cell culture is negative [32].

2.2.2.2. Viral Meningitis diagnose

Viral meningitis (VM) is an infection of the meninges caused by a virus, part of

an aseptic meningitis syndrome. Infections are caused by: Enteroviruses,

Mumps, Lymphocytic Choriomeningitis, Herpes Simplex, Herpes Zoster, and

Arboviruses [33]. Depending on the virus, these viruses enter the central

nervous system by various methods. Once inside the central nervous system,

the viruses spread through the subarachnoid space into the CSF, causing

inflammation that leads to meningitis.

A pleocytosis of lymphocytes is a sign of VM; the white cell count is typically 20

- 500 cells/ml, reaching 1000 cells/ml. Isolation of viruses (in tissue culture) from

CSF is the gold standard for diagnosing many viral pathogens causing

meningitis; however, the procedure is slow, expensive, and not always sensitive

[34]. Currently, the use of PCR to analyze CSF is the most valuable diagnostic

method due to its rapidity, sensitivity, and specificity [35].

13
Miranda-Martínez

In cases of VM, glucose is usually unchanged. On the other hand, proteins tend

to rise slightly to settle at values between 0.5 - 0.9 g/l [28], [35].

Table 3 shows the main components of the CSF in healthy and infectious cases.

Normal Viral Infection Bacterial Infection Tuberculosis infection

Aspect Clear Clear/opaque Turbid Clear/opaque

White cells 0-5 10-2000 100-60000 50-5000

(cells/mm3)
Protein < 0.5 0.5-0.9 > 0.9 (1.0-5.0) > 1.0 (1-5)

(g/l)
Glucose 60-75% Normal < 40% < 50%

(% serum glucose)
Table 3. CSF constituents in different disorders. Obtained from [28]

The distinction between BM or VM is a challenge, especially in patients with

negative Gram stains and cell culture studies; this leads to the evaluation of CSF

viscosity as a parameter to distinguish between the two types of meningitis [34],

[36].

2.2.3. Pleural Effusions

Pleural effusions are an abnormal accumulation of fluid in the pleural cavity.

The origins are mainly excessive production of the liquid, a lack of drainage, or

both [37], [38]. The causes are varied, being mainly: cancer, heart failure,

pneumonia, and tuberculosis [37].

The key point of pleural effusions is the distinction between transudates and

exudates. A transudate is caused when the reabsorption of pleural fluid is

disturbed. Increased pulmonary hydrostatic pressure or plasma osmotic

pressure are alterations that cause transudates. On the other hand, exudates

arise from inflammation or other diseases of the pleural surface, as in cases of

tuberculosis, pneumonia, pancreatitis, pulmonary infarction, or systemic lupus

14
Chapter 2

erythematosus [39]. Differentiation between these two types of effusions is

essential because if a patient has a transudative pleural effusion, only the cause

of the effusion needs to be treated (heart failure, cirrhosis, etc.). However, if it is

an exudative effusion, further testing is necessary to find the cause [40]

2.2.3.1. Diagnosis of Pleural Effusions

The diagnosis begins with an ultrasound or chest x-ray in a decubitus position.

If it is determined that there is a thickness greater than or equal to 2 cm due to

fluid, a thoracentesis will be necessary to study the fluid [37]. The extracted

volume varies depending on the patient's condition, ranging from 5 to 1500 ml,

and, in a few cases, exceeds this maximum [41]. With the extracted sample, the

aim is to classify the fluid between transudate and exudate employing the

"Light's criteria", which contemplates the following:

• Pleural fluid proteins divided by serum proteins > 0.5.

• Pleural fluid lactate dehydrogenase (LDH) divided by serum LDH > 0.6

• Pleural fluid LDH >2/3 (67%) of the upper limit of normal serum LDH

An exudative pleural effusion meets one or more criteria, whereas a transudate

meets none [37], [39].

2.2.3.2. Diagnosis of Pleural Effusions using viscosity

In the works [38], [42] show that viscosity is a parameter that correlates with the

type of exudate. Viscosity is associated with the protein and lipoprotein

concentration of the fluid. By using a viscometer, it was determined that

obtaining the viscosity makes it possible to differentiate between transudates

and exudates, the latter being those of higher viscosity, a result that both

studies agree.

15
Miranda-Martínez

For this reason, there is interest in measuring the viscosity of pleural effusions

to have an efficient, fast, and simple test to avoid the usual biochemical tests,

which can be more costly and time consuming.

2.3. Biopolymer-based hydrogels

Hydrogels are typically formed by polymeric networks of natural or synthetic

origin, crosslinked by covalent or non-covalent interactions [43]–[45]. New

hydrogel systems are continuously being developed to address their current

limitations and expand into new applications. For instance, hydrogels

bioactivity and rheology are engineered to be used as ink to form scaffold

matrices in 3D bioprinting. In situ application will be improved by enhancing

their injectability, which can be done by monitoring the material's viscous

properties [46], [47]. In the design process of such biomaterials, the material's

mechanical properties are critical. For example, the mechanical properties of

implantable hydrogels are often engineered to match those of the surrounding

tissue. The material stiffness can also direct the behaviour of cells, for instance,

by directing the differentiation of stem cells [48] or the growth kinetics of cancer

cells or biopsies [49]. More practically, the mechanical properties will determine

how the gels can be handled and can be used as a marker of biodegradation.

And in vivo, the mechanical properties of natural hydrogel materials also

define their functions. one example is the mucus gel that covers the lung, gut,

cervix, and which depend on their mechanical properties to properly protect

the epithelial surfaces from shear stresses, pathogen infections, and for their

constant recycling and turnover [50]–[52].

16
Chapter 2

2.3.1. Mucins

Mucins are large glycoproteins that coat the surface of many types of cells,

fulfilling functions such as lubrication, hydration, bioactivity, and as a

protective barrier.

The Biopolymers for life group of KTH at the Royal Institute of Technology

(KTH, Stockholm, Sweden) developed and published a novel method to

generate mucins hydrogels by introducing tetrazine (Tz) and norbornene (Nb)

functionalities onto the Bovine Submaxillary Mucin (BSM) molecules [53]. The

protocol leads to the generation of Muc-Tz and Muc-Nb derivatives. When

solutions of Muc-Tz and Muc-Nb are mixed together, they quickly form

covalent bonds and form a hydrogel material (Figure 3). Such hydrogels have

been shown to have interesting immune-modulating properties of interest for

biomedical applications such as encapsulation of cells and microtissue

transplants to dampen the immune reaction and increase treatment efficacy

[54].

Figure 3: Tetrazine (Tz) and norbornene (Nb) conjugated to BSM and the crosslinking reaction

2.3.2. Alginate

Alginate is an algae-derived polysaccharide composed of β-D-mannuronic acid

and α-L-guluronic acid units [46]. This material reacts when cations (𝐶𝑎2+ or

𝐵𝑎2+ ) are added to form an ionotropic gel. This effect generates great interest in

its application in the biomedical field.

17
Miranda-Martínez

It has been proven to be mucoadhesive, biocompatible, and nonimmunogenic,

and it is often processed into microcarriers for cell encapsulation. For bone

tissue engineering, alginate is often combined with calcium phosphates [46]. On

the other hand, alginate is used in 3D bioprinting because it benefits cell

encapsulation and culture by building structures using biocompatible materials

[55].

As opposed to the Muc-Tz/Muc-Nb system, alginate polymers can be ionically

crosslinked by divalent ions (Figure 4), which present different kinetic and

bond strengths compared to covalent bonds formation [53], [56]. With this

system, the strength of the crosslinking varies by selecting two crosslinking

ions. Calcium, which has been extensively used to crosslink alginate into

hydrogels, and barium, owing to its larger size, has been shown to result in

more stable hydrogels, exhibiting less swelling.

Figure 4: Structure of Alginate reacting with 𝐶𝑎2+ and 𝐵𝑎2+ .

2.3.3. Biopolymer-based hydrogels in biomedical applications

Hydrogels are of great interest in tissue engineering and pharmaceuticals due

to their particular physical properties, such as absorbing large amounts of water

and their high biocompatibility [46], [55]. An example of this is their use as cell

18
Chapter 2

encapsulation materials [44], [54], [57]. For the creation of hydrogels, there are

many materials and methods, which will result in a material with unique

mechanical and chemical properties that will define its application, either

medical or pharmaceutical. The following are some of the materials used to

form hydrogels, along with their main applications: Collagen, Gelatin, HA, and

Alginate.

Collagen is a protein present in the extracellular matrix (ECM), of which there

are several types, each one localized in a specific tissue. One of its main

applications is as a scaffold for tissue regeneration such as bone, for which it is

necessary to produce a porous hydrogel by freeze-drying techniques [46]. On

the other hand, by generating scaffolds of cylindrical shapes, collagen can be

used to regenerate blood vessels [58].

Derived from collagen, gelatin has a wide variety of applications, from food to

pharmaceutical. When modified with methacrylamide (GelMA), it has been

used to generate porous scaffolds for bone, cardiac, cartilage, and corneal tissue

regeneration. In addition, due to its electrostatic interactions and structure, it

can be used within drug delivery systems [46], [59].

HA is a polysaccharide that is the main component in the extracellular matrix of

the skin, cartilage, and vitreous humor. It can be used as a material for eye

surgery [60] and is often combined with other materials for nerve regeneration

and blood vessel formation applications [46].

Alginate is another polysaccharide obtained from marine algae. Its soft gelling

behavior allows encapsulation of sensitive bioactive molecules or cells. When

combined with a multivalent ion such as calcium, it forms a hydrogel used for

cell encapsulation [55]. In addition, [61] shows the use of alginate microspheres

for cell immobilization for bone tissue regeneration purposes.

19
Miranda-Martínez

A recent growing application is in 3D bioprinting, which benefits cell

encapsulation and culture by building structures using biocompatible materials

such as those mentioned above. In this application, the mechanical properties of

the hydrogels (gelation time, viscosity, etc.) must meet specific conditions to

generate the 3D structure [62]–[66].

Another essential element is mucins. Mucins (Muc) coat the surface of many

types of cells, having unique properties and fulfilling functions such as

lubrication, hydration, bioactivity, and as a protective barrier. For this reason,

their use as biomaterials has become widespread, mainly in areas such as tissue

engineering [67]. Recent research shows the use of bovine mucins for the

generation of hydrogels. As mentioned earlier, Muc-Tz and Muc-Nb can be

assembled to form a hydrogel material (whose process is fully detailed in [53])

with interesting properties.

The main idea to highlight about hydrogels is that their production involves

many factors that will result in specific mechanical properties, viscosity being

one of these. Therefore, viscosity is a parameter of interest when studying,

generating, and applying hydrogels and requires precise control and

evaluation.

2.4. The importance of the clinical use of viscosity in human fluids

In the world of medicine, the study of the physical and chemical properties of

the fluids of the human body is essential when identifying pathologies. One

physical property that has been little exploited is viscosity. Correct viscosity

measurement is a helpful factor in the accurate diagnosis of many diseases;

some cases are exposed hereunder.

The distinction between Transudative and Exudative Pleural Effusions (TPEs

and EPEs) in pleural diseases is essential [38], [42], [68]. Currently, this

20
Chapter 2

discrimination is based on some biochemical tests that are relatively costly and

time-consuming. Lymphocyte-predominant EPE results from many diseases,

with malignancy, tuberculosis being the most common among them. However,

pleural fluid viscosity can reliably differentiate between TPE and EPE [38], [42],

and there is even evidence correlating this viscosity with pathologies such as

tuberculous pleurisy and lung cancer [69]. The measurement of Cerebrospinal

Fluid viscosity is a simple and easy process that can be used as an adjunctive

measure for diagnosing meningitis having a role in the discrimination of

bacterial versus aseptic meningitis [36]. Early diagnosis of acute meningitis has

paramount importance in clinical practice because of mortality and morbidity

of the disease. In arthropathies, synovial fluid exhibits a change in viscosity that

can be linked to an inflammatory response to infection and other causes. For

example, in rheumatoid arthritis cases, the viscosity of the synovial fluid

decreases because of reduced production and polymerization of hyaluronic acid

[20], [22], [24]. Another case of interest is that of blood plasma. Plasma is a

highly concentrated solution of proteins whose viscosity usually remains stable

and, when varying slightly, can provide valuable information for detecting

pathologies. Cases of high viscosity in plasma are correlated with coronary and

peripheral artery diseases [70].

Although viscosity is a property that can be useful for disease diagnosis, it has

been little exploited. On the one hand, in many cases, the volume of fluid

extracted is scarce to measure its viscosity adequately since the existing options

usually require a larger sample volume. On the other hand, in cases where it is

analyzed, this analysis depends on the subjective interpretation of the

examining physician. To these considerations can be added the high cost of

viscosity measuring instruments.

21
Miranda-Martínez

2.5. Viscosity measurement techniques

The concept of viscosity will be discussed in detail later in this work, but now

we will generally describe the instrumentation currently used for its

measurement. In summary, we can group viscosity measuring instruments into

two categories: viscometers on the one hand and rheometers on the other. In the

first group, the measuring principle is detecting the resistance generated by a

fluid when a flow (preferably isometric) is generated. This will provide a

measure of the fluid's viscosity as a function of the flow velocity generated.

Rheometers are complex instruments that allow characterizing the viscoelastic

properties of fluids. They allow obtaining more parameters of the sample, such

as the elastic modulus and the viscous modulus. A brief overview of the most

used viscometers/rheometers is given below.

2.5.1. Rotational rheometers/viscometers

One of the most common instruments for measuring viscosity, rotational

viscometers base their operation on measuring the resistance to the flow of a

fluid and having the main advantage of operating continuously at one shear

rate. This is achieved when a flow is generated within a space where the sample

is contained. The most common are concentric cylinders, cone-plate, and

parallel plate viscometers.

There are different methods of operation. One is the Searle type viscometer,

where the inner cylinder is the one that rotates (for concentric cylinder

viscometers, for the others, it would be the cone or the upper plate). The other is

the Couette type, where the outer cylinder rotates (the lower plate in other

cases). In addition, it is common to control the shear rate and measure the shear

22
Chapter 2

stress, however, there are instruments where the stress is controlled, and the

shear rate is measured [16], [17], [71].

The advantages of this type of instrument are the possibility of measuring the

viscosity of fluids regardless of their transparency or opacity. It also allows

time-dependent measurements and can make semi-automated measurements.

Furthermore, in some cases, non-Newtonian fluids can be measured. However,

they are expensive devices depending on their complexity (costs vary from

approximately $2000 and can reach up to $10,000 or more), and they become

large and difficult to transport.

2.5.1.1. Concentric cylinders

It consists of an inner cylinder (also known as bob) which has a radius R1 and

an outer cylinder of radius R2 (Figure 5). The liquid to be measured is placed in

the internal space between the two cylinders. As a cylinder rotates at a constant

speed (𝛺 [rad/sec]), the fluid will generate resistance to motion causing the

torque (T [dyne cm]) to be measured. The torque is related to the dynamic

viscosity (𝜂 [Pa·s]) of a Newtonian fluid by the Equation (2) [16], [71]:

4𝜋𝑅12 𝑅22 ℎ𝜂𝛺 (2)


𝑇= = 𝐶𝜂𝛺
𝑅22 − 𝑅12

Where C is a constant specific to the instrument and h is the height of the inner

cylinder that is covered by the fluid.

Figure 5. Basic structure of concentric cylinders viscometer

23
Miranda-Martínez

2.5.1.2. Cone and plate

This shape allows a uniform shear rate to be generated, which makes it useful

for measuring the viscosity of Newtonian and non-Newtonian fluids. The

uniform shear rate is achieved when the angle between the cone and the plate is

reduced (α< 0.05 rad) [16], [71]. Usually, the angle α is less than 0.1 rad

(approximately 6˚). By obtaining the torque value, the fluid viscosity can be

obtained by Equation (3) [71].

3𝑇𝛼 𝐶𝑇 (3)
𝜂= =
2𝜋𝑅 3 𝛺 𝛺

Where, C is an instrument constant typically provided by de manufacturer, T

is the torque, 𝛺 is the angular speed and R is the radius of the cone. Figure 6

illustrates Cone and Plate structure.

Figure 6. Basic structure of cone and plate viscometer

2.5.1.3. Parallel plate

This geometry is very similar to the cone and plate geometry except that instead

of the cone, another plate is placed (observe Figure 7). In this case, the shear

rate loses uniformity because it depends on the distance between plates h and

the radial distance to the axis of rotation R. The torque T is related to the

viscosity of a Newtonian fluid by equation (4) [16].

24
Chapter 2

2𝑇ℎ (4)
𝜂=
𝜋𝑅 4 𝛺

Where 𝛺 is the angular speed.

Figure 7. Basic structure of parallel plates viscometer

2.5.2. Capillary viscometers

This category includes a varied number of instruments; however, they all

operate with the same principle, which is to pass fluid (Newtonian fluid) from

one tube to a smaller one called capillary to measure the volumetric flow rate

along with the time it takes for the entire volume to pass through the

graduation marks on the instrument (Figure 8). The liquid can flow through the

capillary either by the influence of gravity or by an external force such as a

piston [16], [17].

Its operation is usually simple with a relatively low sample volume (a few

milliliters) and has good temperature control and a cheaper cost than the rest.

On the other hand, they have difficulty being cleaned. Depending on the range

of viscosities to be measured will be the instrument's dimensions, which

conditions to have several tubes to measure a wide range of viscosities.

The viscosity calculation using glass capillaries is based on the Poiseuille

equation. The expression is illustrated in equation (5) [71].

𝜋𝑔ℎ𝐷 4 (5)
𝜂= 𝜌𝑡
8𝑙𝑉

25
Miranda-Martínez

Where rho is the density of the fluid, g is gravity, h is the height of the fluid

surface, D is the diameter of the capillary, l is the length of the capillary, V is the

defined volume of the liquid and t is the time required for the volume to flow

between the graduated marks of the viscometer.

Figure 8. Basic structure of capillary viscometer

2.5.3. Falling body method

The Falling Body Method relates the velocity at which an object (a sphere or a

cylinder) falls through the viscous fluid with the viscosity of the liquid. In

Figure 9, a basic diagram of this method is illustrated. Other parameters related

are the dimensions of the container, the densities of the fluid and the object, and

the force of gravity. This method consists of marking a start and an end on the

container to establish the distance d that the object will travel. When the object

falls between the two marks at its terminal velocity, the displacement time is

measured to calculate the velocity and viscosity. The measuring range can be

adjusted by changing the density or the dimension of the object. It is often used

to measure low or medium viscosities of Newtonian fluids that must be

translucent, and it requires approximately 40 ml sample volume to perform the

viscosity measurement [16], [17].

For the case of a falling sphere, the relationship between the object's velocity

and the fluid's viscosity is seen in Equation (6) [16].

26
Chapter 2

(𝜌2 − 𝜌1 ) (6)
𝜂 = 2𝑔𝑟 2
9𝑈𝑡

Where 𝜂 is the absolute viscosity, r is the radius of the sphere, g is the gravity

force, 𝜌2 is the density of the sphere, 𝜌1 is the density of the fluid and 𝑈𝑡 is the

terminal velocity.

Figure 9. Basic structure of falling body viscometer

2.5.4. Ultrasonics

Viscosity can also be measured using ultrasonic waves (frequencies between

104 and 108 Hz ). This is achieved by detecting the absorbed energy of the

acoustic wave transmitted through the fluid. The measurement method consists

of placing two transducers so that one emits the acoustic wave, which passes

through the liquid and is received by the other transducer, which detects the

decay of the signal.

This method is technically more complex than the others, so it has not been

positioned as a basis within the methods for measuring viscosity [16].

2.6. Quartz Crystal Resonators

Quartz Crystal Resonators (QCR) are elements that take advantage of the

piezoelectricity of quartz, which can be summarized as the ability to generate

27
Miranda-Martínez

an electrical charge when the crystal is subjected to mechanical stress.

Conversely, when the crystal is subjected to a potential differential, it will

experiment a deformation depending on its physical shape [2], [72], [73]. There

are a great variety of quartz cuts that serve different applications. In this thesis,

we will talk specifically about AT-cut crystals, which work in thickness shear

mode.

To excite the quartz crystal, it is usually placed in the middle of two electrodes

(Figure 10). These electrodes are usually made of conductive metals such as

gold, silver, and copper. In this work, we will focus on gold electrodes.

Figure 10. QCR schematic.

As mentioned earlier, when the QCR is excited with an AC signal, it will suffer

a shear deformation (it will vibrate), as shown in Figure 11; and when the

frequency of this signal coincides with one of the acoustic resonance frequencies

of the quartz plate, the amplitude of the oscillation will be large, and so will be

the electric current consumed by the electrode [2]. This frequency is called the

fundamental resonance frequency of the QCR.

Figure 11. Shear deformation during oscillation in QCR

28
Chapter 2

The crystal's vibration depends on its thickness; for example, a crystal with 330

µm thickness will vibrate at a frequency of 5 MHz and one with 168 µm at 10

MHz. On the other hand, gold electrodes usually have a thickness of 0.1 µm

[74]. This relationship is illustrated in Equation (7) [2].

𝑣𝑞 (7)
𝑓0 =
2𝑑𝑞

where 𝑓0 is the fundamental resonance frequency, 𝑣𝑞 is the wave speed for

quartz, and 𝑑𝑞 is the thickness of the quartz.

2.6.1. Butterworth-Van Dyke model

A common representation of the crystal is the electrical circuit known as the

Butterworth-Van Dyke (BVD) equivalent circuit (Figure 12) derived from

Mason equivalent circuit [75]. This model explains the crystal behavior near its

resonance frequency and is composed of two arms; the first is the motional arm,

and it has three series components: 𝑅1 , 𝐿1 , and 𝐶1 . 𝑅1 models the dissipation of

the oscillation energy from the medium in contact with the crystal, 𝐿1 is the

inertial component of the oscillation and is related to the displaced mass while

the crystal is vibrating, 𝐶1 models the stored energy and is associated with the

elasticity of the quartz. The second arm contains a parasitic capacitance in

parallel (𝐶0 ); this capacitance is related to the sum of the crystal’s electrode’s

static capacitances. When the crystal is in contact with a liquid load, one

element is added to the first branch, 𝑍𝐿 is the loading from the liquid sample

[76].

Figure 12. Butterworth-Van Dyke model of Quartz Crystal Resonators (QCR) with liquid load.

29
Miranda-Martínez

The circuit elements can be calculated theoretically with the Equation (8) for a

specific resonance frequency [77]:

𝜀22 𝐴 (8a)
𝐶0 = ,
𝑑𝑞

8𝐾02 𝐶0 (8b)
𝐶1 = ,
(𝑁𝜋)2

1 (8c)
𝐿1 = ,
𝜔𝑠2 𝐶1
𝜂𝑞 𝜔 2 (8d)
𝑅1 = ( ) ,
𝑐66 𝐶1 𝜔𝑠

where 𝜀22 is the quartz permittivity, A is the electrode surface area, 𝑑𝑞 is the

quartz thickness, 𝐾0 is the electromechanical coupling constant for quartz, N is

the overtone number =1, 3, 5, …, 𝜔𝑠 is the angular series resonant frequency for

the unperturbed QCR = 2π𝑓𝑠 , 𝑓𝑠 is the series resonant frequency in hertz, ω is

the angular excitation frequency = 2πf, 𝜂𝑞 is the effective quartz viscosity, and

𝑐66 is the quartz elastic constant.

Under certain conditions, Equation 8 may be inaccurate; therefore, it is

proposed to use another type of characterization based on impedance analysis

[78], [79].

According to Figure 12, the equivalent admittance at BVD circuit can be written

as [80]:

1 (9)
𝑌= + 𝑗𝜔𝐶0 ,
1
𝑅1 + 𝑗𝜔𝐿1 + + 𝑍𝐿
𝑗𝜔𝐶1

where 𝑍𝐿 is the viscosity from the liquid load:

𝑡2 𝜔𝜂𝐿 𝜌𝐿 𝜔𝜂𝐿 𝜌𝐿 (10)


𝑍𝐿 = 2 [√ + 𝑗√ ],
4𝑒35 𝑆𝑒 2 2

30
Chapter 2

2
where t is the thickness of the quartz plate, 𝜔 is the angular frequency, 𝑒35 is the

piezoelectric constant, and 𝑆𝑒 is the electrode area.

Also, the conductance is expressed as:

𝑅1 + 𝑅𝑒 [𝑍𝐿 ] (11)
𝐺= ,
1
(𝑅1 + 𝑅𝑒 [𝑍𝐿 ])2 − (𝜔𝐿1 + 𝐼𝑚 [𝑍𝐿 ] − 𝜔𝐶 )2
1

From the equivalent circuit, we obtain 𝑓𝑠 , which occurs at the maximum

conductance point [81]. According to the electrical model, when the crystal is in

contact with a fluid, the peak of conductance is displaced in frequency to a

minor frequency and decreasing its magnitude (Figure 13); this maximum

conductance can be located by performing a frequency sweep that encloses the

fundamental resonance frequency of the crystal.

Figure 13. Frequency response of QCR conductance with and without sample.

The frequency bandwidth of the QCR is very narrow, which makes them have

excellent accuracy. This sharpness is quantified by the Q factor where Q = 𝑓/2Γ

with 𝑓 as the resonance frequency and Γ as the half-bandwidth at half

maximum (Figure 13). The shift in half-bandwidth at half-maximum (ΔΓ) is

related to the energy transferred from the crystal to the sample over time and

can provide information on the viscoelastic properties of the sample; also is

used as dissipation D = 1/Q [2].

31
Miranda-Martínez

Another way to visualize 𝑓𝑠 is through an admittance diagram (Figure 14). On

the horizontal axis is the conductance G and on the vertical axis is the

susceptance B. This diagram shows three resonant frequencies representative of

a QCR: 𝑓𝑚 , 𝑓𝑠 , and 𝑓𝑟 . 𝑓𝑚 is the resonant frequency located at the maximum

admittance point (Y), 𝑓𝑠 is the aforementioned series resonant frequency located

at the maximum conductance point (G), and 𝑓𝑟 is the zero-phase resonant

frequency located at the point where the susceptance value (B) is zero [79], [81].

Figure 14. QCR admittance locus

2.6.2. Mass deposition

One of the main applications of QCRs is as a mass sensor, commonly known as

Quartz Crystal Microbalance (QCM), whose origin derives from research

conducted by Günter Sauerbrey. The relationship between the change of the

resonant frequency of the QCR with the added mass is illustrated in Equation

(12) [3].

2𝑓0 2 (12)
∆𝑓 = − 𝐴 ∆𝑚,
√𝜌𝑞 𝐺𝑞

∆𝑓 = 𝑓𝑠 − 𝑓0 , (13)

32
Chapter 2

where ∆𝑓 is the frequency shift, 𝜌𝑞 = 2.648 g·𝑐𝑚−3, and 𝐺𝑞 = 2.947 x 1010 𝑁 ·

𝑚−2 are the specific density and the shear modulus of quartz respectively, A is

the piezoelectrically active crystal area, and ∆m is the thin film of mass

deposited.

Strictly speaking, a QCM sensor measures an areal mass density in units of

mass per area beyond measuring mass, and instead of measuring “micro”

masses it senses units near to “nano” masses. An important note is that the

equation described by Sauerbrey only applies when the sample is rigid and free

of a liquid environment (in this case, ∆𝛤 << ∆𝑓). In gravimetric cases where

there is contact with liquids, two frequency changes will accumulate due to: a

mass deposition and the contact with liquid [2].

2.6.3. Fluid deposition

When the sample placed on the QCR is a liquid, the crystal surface movement

generates a shear wave that propagates into the deposited fluid; consequently,

this wave will suffer a damping effect. The connection between the frequency

shift and the fluid's density-viscosity product contact with the crystal is given

by the Gordon-Kanazawa relationship, Equation (14) [4]. Although the equation

is attributed to authors J. G. Gordon and K. K. Kanazawa, the equation was

described in Mason's earlier work [82].

3 𝜌𝐿 𝜂𝐿 (14)
∆𝑓 = −√𝑛 𝑓0 2 √ ,
𝜋𝜌𝑞 𝐺𝑞

where 𝜌𝐿 is the fluid's density, 𝜂𝐿 is the fluid's viscosity, and n is the overtone

number; in this work, the fundamental frequency of the crystal is used; thus, n =

1.

However, this relationship has been derived theoretically for an infinite quartz

plate without interfacial slip and for the case of a perfectly smooth surface. In

addition, some effects make viscosity measurement difficult, such as roughness

33
Miranda-Martínez

and nanoscopic air bubbles; consequently, the use of this equation has not

proved to be reliable when measuring the density-viscosity product of

Newtonian fluids [83], [84].

As Johannsmann mentions in his work ([34], [47]), it is essential to clarify that

the 𝜂𝐿 viscosity obtained by the QCR (MHz viscosity) is different from the

steady shear viscosity. Moreover, QCR doesn't measure the high shear viscosity

unless it is claimed that the high frequencies mimics the behavior at high shear.

2.6.3.1. Complex viscosity

To obtain the viscoelastic properties of the sample, Johannsmann determines

the relationship between the complex viscosity with ∆𝑓 and ΔΓ [2]:

𝐺´´𝐿 𝜋𝜌𝑞 𝐺𝑞 𝛥𝑓𝛥𝛤 (15)


𝜂´𝐿 = 𝜔
=− 𝜌𝐿 𝑓𝑠 𝑓02
,

𝐺´𝐿 1 𝜋𝜌𝑞 𝐺𝑞 (𝛥𝛤 2 −𝛥𝑓2 ) (16)


𝜂𝐿´´ = 𝜔
=2 𝜌𝐿 𝑓𝑠 𝑓02
,

∆𝛤 = 𝛤𝑠 − 𝛤0 , (17)

where 𝜂´𝐿 and 𝜂𝐿´´ are the real and the imaginary components of the viscosity

respectively, 𝐺´ and 𝐺´´ are the real and the imaginary components of the shear

modulus for the liquid, ω is the angular frequency, and ΔΓ is the half-

bandwidth at half maximum shift. For Newtonian fluids, ∆𝑓 and ΔΓ are equal

and opposite (𝜂´𝐿 = constant, 𝜂𝐿´´ = 0 ). For viscoelastic fluids: 𝜂´𝐿 = 𝜂(𝜔), 𝜂𝐿´´ ≠ 0.

2.6.4. Penetration depth

It is important to note that QCRs measure in the region closest to the crystal

surface. The shear wave decays as it penetrates the fluid as follows (Figure 15)

[84]:

2𝜂 (18)
𝛿 = √𝜔𝜌𝐿 ,
𝐿

34
Chapter 2

Where δ is the penetration depth. In water, the penetration depth for a crystal

with 𝑓 = 10 MHz is about 178 nm.

Figure 15. Decay depth of the acoustic wave transmitted to the fluid.

2.7. QCRs used as viscometers

The use of QCR's as tools for measuring viscosity has only recently begun to be

explored, and there are few examples of their use for this purpose. One such

case is illustrated in [85], where QCRs are used to measure the viscosity of

droplets of various industrial oils to determine the operating condition of the

oils. A further case is documented in [86]. Here the authors measure the

viscosity of battery acids using QCRs to assess their state of charge. On the

other hand, in [87], the authors estimate the viscosity of different solutions such

as sucrose, glucose, or ethylene glycol using a volume of the order of microliters

and based on an impedance analyzer.

2.8. Brief description of artificial neural networks

Artificial neural networks (ANNs) are a segment of Artificial Intelligence (AI)

that, based on examples, can induce concepts. They are data processing systems

whose operation is based on the networks of neurons in the brain [88], [89].

These tools help find relationships between data and also in classification and

prediction. They can also improve their performance by using information

obtained from previous tasks.

35
Miranda-Martínez

Its use has been increasing in many areas of engineering, and biomedical

engineering is no exception. Some examples of ANN applications in

bioengineering can be found in: [88]–[91].

The basic model of these ANNs (known as the multilayer perceptron model) is

shown in Figure 16. It is composed of three types of layers: an input layer, an

output layer, and hidden layers. This type of model allows information to flow

in one direction, from input to output and is known as a feedforward neural

network. In this way, data will enter the network's input nodes, then be

processed in the hidden layers, and finally deliver the processed data to the

output layer [89].

Figure 16. Basic ANN model.

There are three main categories for ANN learning [88]:

1. Supervised learning. Expected outputs are delivered to the network, and

the network is trained to respond appropriately.

2. Unsupervised. The expected outputs are not provided in advance, and it

is expected to find structures present in the inputs.

3. Reinforcement. Expected outputs are not delivered, and instead,

performance indicators are provided periodically.

36
Chapter 2

For the case of the present work, a supervised learning technique will be used

with backpropagation algorithm for training. A brief comparison of the results

will be made by modifying the number of hidden layers (between one and two)

and the number of training epochs (100, 200, and 300). A more extensive study

with a more significant number of configurations is possible as the field of

ANNs is vast; however, it is beyond the intended scope of this thesis.

2.9. ViSQCT project and previous work

The ViSQCT (Viscosity Detection by Quartz Crystal Techniques) project arose

in the LBN of the CTB of the Universidad Politécnica de Madrid (UPM) in 2017

as the continuation of a previous project where the theory for the application of

QCRs to measure the viscosity of biological samples with reduced volume was

put forward. Positive results showing the feasibility of using QCRs for this

purpose were obtained from this previous project along with a first prototype

of the sensor, two journal publications [92], [93], and a Ph.D. thesis [94].

Essential aspects of the prototype design are the sweep signal generation

module and the electronics for obtaining and converting the voltage, current,

and susceptance signals from analog to digital. Together with the power supply

of the system, both concepts are explained below.

2.9.1. AD9850 module

The Analog Devices AD9850 module was used to generate the frequency

sweep. This device uses DDS (Direct Digital Synthesis) technology in

conjunction with a high-speed digital-to-analog converter to create

programmable digital waveforms. An Arduino Due board was used to program

and adjust the AD9850, which will be discussed later. The module is adjusted to

perform the desired frequency sweep through serial communication. The

sweep range of the device is from 1 Hz to 40 MHz. Usually, the sweep used is

37
Miranda-Martínez

50 kHz at frequencies close to 10 MHz, which is the fundamental resonance

frequency of the QCRs used.

2.9.2. Analog to digital stage

The analog voltage, current, and susceptance signals are converted to digital

signals by an Arduino Due board, which will create a data frame of each and

send them to the LabView software on the computer via serial. On the other

hand, Figure 17 shows a diagram illustrating how the analog signals are

obtained. The left branch indicates the frequency sweep generation stage, and

the right branch shows the signals measured after QCR excitation.

Figure 17. Simplified diagram of the signals acquisition system.

2.9.3. Power supply

The circuit is designed to work with two 9 volt batteries in conjunction with

two voltage regulators at 5 and -5 volts (LD1117 and MC7905, respectively).

These will power the board and the AD9850 module. The Arduino due board is

powered with the same USB cable with which it communicates with the

computer. With these elements, the operating time of the sensor is

approximately three hours.

With this previous work, the ViSQCT project begins with designing and

constructing a new version of the sensor prototype for further evaluation as a

clinical tool.

38
Chapter 3

3. Hypothesis and Objectives

3.1. Hypothesis

There is evidence on the importance of viscosity as an essential factor in the

characterization of biological fluids, either to determine the health status or to

develop new biocompatible materials. On the other hand, Quartz Crystal

Resonators demonstrate their applicability as sensors that allow determining

the viscosity of a low volume sample of a fluid, which helps the medical field

by generating small, inexpensive, and accurate equipment with clinical and

research and development applications.

As mentioned in the introduction of this work, current methods to determine

viscosity are expensive, bulky, or slow and often require sample volumes not

available in several biological cases. For this reason, this work proposes that it is

possible to design and develop a portable, low-cost QCR-based sensor that,

together with a methodology, can be used to measure the viscosity of a scanty

volume sample to assist in medical applications as a diagnostic and biomaterial

characterization tool.

3.2. General and specific objectives

The main objective of this doctoral thesis is to develop and validate an

enhanced low-cost QCR-based sensor within its methodology to measure the

viscosity of a sample with reduced volume.

To meet the proposed objective, the device must have a space where the QCR

can be easily placed, allowing the sample to be deposited by pipetting. Finally,

the QCR must be removed from its holder and cleaned adequately at the end of

the measurement.

39
Miranda-Martínez

This development involves four parts that are considered as specific objectives:

design, development, phantoms development, and validation.

1. Design the sensor electronically and mechanically, being the electronic

part the sensor circuit (with its control system), and the mechanical part

the holder that allows isolating the samples. This part seeks to update the

work previously done within the project to enhance the sensor, reduce its

size, and improve its performance.

2. Physical construction of the device at the electronic and hardware level.

The measurement protocol and the crystal cleaning protocol will also be

defined.

3. Search and (or) development of samples. This objective is divided into

two. The first is the development of phantoms that mimics de viscous

properties of human fluids, such as Cerebrospinal Fluid and Synovial

Fluid. The purpose of this is to evaluate the sensor's performance for its

possible application in cases where the measurement of this type of

fluids is required. The second is to search for biomaterials whose

viscosity characterization is relevant for its development. This is

intended to test the capabilities of the sensor in the area of materials.

4. Finally, the validation of the device is required by measuring real

samples. The results of measuring human fluids will allow an evaluation

of the sensor's capabilities as a diagnostic tool. On the other hand, the

results as a biomaterial characterization tool will provide the possibility

of a second approach to the sensor, venturing into the area of biomaterial

development.

40
Chapter 5

4. Sensor Development

In this chapter, the sensor design is detailed. It is important to clarify that this

design is based on a previous prototype that was outdated.

In general, the hardware was improved by reducing its size and optimizing the

signal amplification stages by replacing the analog potentiometers with digital

potentiometers. These changes influenced the software, which was enhanced.

Portability and low cost are essential system requirements. On a technical level,

the ability to measure the resonant frequency of the QCR (sampled and

unsampled) by means of a frequency sweep was maintained. In addition, the

prototype must allow the static measurement of the sample while complying

with the facilities for fluid deposition and subsequent washing of the crystal.

4.1. Sensor description

As discussed in Chapter 2, the series resonance frequency (𝑓𝑠 ) of the QCR (along

with the half-bandwidth) changes when the crystal is in contact with a fluid.

Once the 𝑓𝑠 is located (when G is maximum), a viscosity value can be obtained

using equation 14 . This is by measuring 𝑓𝑠 without sample and then 𝑓𝑠 with the

sample to calculate ∆𝑓. Such ∆𝑓 can also be used as a characterization

parameter. As for sensor operation, the way to locate 𝑓𝑠 is by mapping G at

frequencies close to 𝑓0 . For this, it is necessary to excite the crystal with a sweep

of frequencies close to 𝑓0 . The response of the QCR to this stimulus must be

obtained to obtain G at each frequency of the sweep and thus observe the

maximum point of G. The signals measured as crystal response at each

frequency are voltage (V), current (I), and susceptance (B). A diagram of this

process can be observed in Figure 18.

41
Miranda-Martínez

Figure 18. Excitation and signal acquisition process in the QCR.

Considering the above mentioned, we can reduce the elements that make up

the prototype to three: electronic, software, and mechanical parts. The electronic

part consists of three parts, and the first one is the frequency sweep generation

that will excite the QCR. Subsequently, there is the signal acquisition stage,

where the signals measured from the crystal response must be treated and

digitized for subsequent analysis and storage. The last stage is the power

supply of the device. The software used to control the prototype is LabView

from National Instruments®, which is used to configure the device to perform

the required measurements and subsequently store the data obtained.

4.2. PCB design

The design of the electronic board was made with Altium software. The

objective was to have the smallest possible dimensions and allow the Arduino

due board and the AD9850 module to be coupled. For this purpose, four

X9C103 digital potentiometers were added to control the amplification stage of

the signals, replacing the analogue potentiometers used in previous versions.

42
Chapter 5

Figure 19 shows the digital design of the board, the upper image is the top side

of the circuit (where the AD9850 circuit is coupled), and the lower image is the

bottom side (where the Arduino due board is mounted).

Figure 19. PCB design

Once we had the design, the next step was to manufacture the board. Figure 20

shows the PCB used without the components mounted. Again, the upper image

is the top side of the circuit, and the lower is the bottom.

43
Miranda-Martínez

Figure 20. PCB manufactured

The last stage of the PCB was to solder the components. After this, the correct

operation of the circuit was checked by testing the correct generation of the

frequency sweep and the correct obtaining of the signals of interest. Figure 21

shows this circuit evaluation stage.

Figure 21. Evaluation of the mounted PCB.

44
Chapter 5

4.3. QCRs an holder cell

This work was developed using QCR with 𝑓𝑠 = 10 MHz, gold electrodes,

electrode dimensions of 5 and 11 mm, roughness < 1 nm, and mounted in HC-

51 holder. The crystals were purchased from Krystaly (Hradec Králové, Czech

Republic). Figure 22 shows the QCRs employed. The specific dimensions

(provided by the supplier) are illustrated in Figure 23.

Figure 22. QCRs used in measurements.

Figure 23. Dimensions (in mm) of the QCRs.

On the other hand, it was necessary to manufacture an enclosure where the

crystal could be placed during the measurements and where the liquid to be

measured could be deposited. The design of this holder cell is based on the one

used in the first Open QCM® (Novaetech S.r.l., Naples, Italy) device. The lid

was modified and adapted to the needs of this work by creating an area that

allows access to the crystal, and where the sample to be measured is kept static

for measurement. Two silicone rings contain the crystal, one located in the lid

and the other in the base. Figure 24 shows the 3D design of the lid. The finished

enclosure can be seen in Figure 25, fabricated from PLA using a 3D printer.

Figure 26 illustrates the QCR placed in the holder cell.

45
Miranda-Martínez

Figure 24. Design of the lid required for the holder cell.

Figure 25. Holder cells manufactured in a 3D printer using PLA.

Figure 26. QCR placed in the holder cell.

4.4. System control and user interface

The system is controlled by a program developed in the LabView environment

of National Instruments®. The program was produced before this work and was

adapted for the new device. It allows configuring the values required by the

AD9850 for the frequency sweep through user input. After the sweep, it

receives the digital signals of voltage, current, and susceptance to plot the

received signals and provide the 𝑓𝑠 and Γ data. This process can be repeated N

number of times, where the user sets N. On the other hand, the program allows

the activation of the gain increase in the amplification stage of the measured

signals. This is important because the measured signals are attenuated when

46
Chapter 5

measuring the 𝑓𝑠 of the sampled crystal, so it is necessary to amplify them for

accurate detection.

The main program window is shown in Figure 27. In this window, a first

configuration is observed before being executed. A directory must be

established where the information is stored, and the communication port where

the Arduino board is connected must be identified. The "Sample" button is also

activated for the sample measurement. At the end of the measures, a results

window is displayed showing the conductance and susceptance curves

obtained in each cycle, as shown in Figure 28. A flow chart of the program is

illustrated in Figure 29.

Figure 27. Main window.

Figure 28. Results window.

47
Miranda-Martínez

Figure 29. Simplified flowchart of the program algorithm.

4.5. 3D printed case

Once the device's functionality was demonstrated, a case was elaborated to be

placed for protection from the outside. It was designed for the sensor's

dimensions with ventilation openings and spaces where the cables for the

batteries, the QCR, and USB can pass. The case material is PLA and was built

with a 3D printer like the QCR holder cell. Figure 30 shows the digital design of

the lid and base, and Figure 31 shows the case once printed.

48
Chapter 5

Figure 30. Design of the lid and the base of the case.

Figure 31. 3D printed case.

4.6. Final prototype

The final device (named as ViSQCT sensor) can be seen in Figure 32 without the

holder cell, batteries, and case. It weighs less than 100 g, and costs less than

200€. Figure 33 exhibits the sensor components in operation, and Figure 34

reveals the complete system working.

Figure 32. ViSQCT sensor

49
Miranda-Martínez

Figure 33. System elements.

Figure 34. Complete system operating.

50
Chapter 6

5. Protocols and Preliminary Measurements

Once the ViSQCT sensor has been developed, the experimentation stage

follows. For this, it is necessary to define the measurement and cleaning

protocols to be used in the measurement stage. With the protocols established,

preliminary measurements were made with common fluids to observe the

sensor's response.

It is important to note that, in these first measurements, QCR’s from a first

batch purchased were used. The measurements shown in the following

chapters were performed with a new batch of QCR’s.

This chapter will present the mentioned protocols and the results of the first

measurements with the sensor.

5.1. Measurement protocol

The development of the experiments was carried out with the following

measurement protocol.

1) Connect the sensor to the computer using a USB. Ensure that you select

the appropriate communication port in the program to enable the

connection with the sensor.

2) Place the QCR in the holder cell, carefully close the lid, and connect it to

the sensor.

3) Connect the two batteries to the sensor.

4) Configure the software to measure without sample. Start the

measurement and obtain the 𝑓𝑠 .

5) Transfer the data obtained for analysis.

6) Add the sample to be measured on the crystal. Usually, the sample

volume is 50 µl, but this may vary.

51
Miranda-Martínez

7) Repeat the measurement by configuring the software to measure with

the sample.

8) Transfer the data obtained for its analysis. With the data obtained from

point 4, get viscosity values using Equation (14).

9) The entire process must be repeated to have several data from the same

sample.

5.2. QCR cleaning protocol

After each experiment, the QCR must be carefully removed from its container

for cleaning.

For cleaning, it is necessary to use nitrile gloves and prepare the following

solutions.

First solution. Weigh 1 gram of Sodium Dodecyl Sulfate (SDS) and add it to 50

ml of distilled water. This mixture will serve as a detergent to clean the glass

removing residues.

Second solution. Make a 70% ethanol mixture. This solution will be used to

disinfect the QCR.

Once the above solutions are ready, we apply the following cleaning protocol.

First, rinse the QCR with the SDS solution until the residues are removed. If the

crystal is still dirty, it will be necessary to moisten the nitrile glove and rub the

glass very gently. Then rinse with distilled water. If performing measurements

with biological fluids, it is essential to sterilize the QCR. For this purpose, it can

be rinsed with 70% ethanol. Onetime disinfected, it is rinsed with distilled

water and dried with air to be used again.

52
Chapter 6

5.3. Open QCM

As we began to evaluate the performance of the ViSQCT sensor, we considered

it interesting to compare results with a similar sensor that is available on the

market. With this comparison, we will be able to observe if there are similarities

in the results and advantages and disadvantages in the use of both sensors.

The selected sensor is Open QCM Q-1® (Novaetech S.r.l. Italy), an open-source

sensor designed for continuous measurement [95].

This sensor can measure the resonance frequency by making a frequency sweep

and using a gain-phase detector that compares the exciting signal entering the

crystal with the signal at the crystal output (Figure 35). The device was adapted

to be connected to the QCRs used by adding a pair of clip wires to the device's

output.

Although both devices can measure the resonance frequency with a frequency

sweep, the range covered by this sweep is different. In the ViSQCT sensor, the

frequency range is 50 kHz, allowing longer measurement times and a higher

resolution when measuring larger ∆𝑓 (high viscosities). On the other hand, the

Open QCM sensor has a frequency sweep range of 11 kHz, making the

measurement capture faster but difficult when measuring huge ∆𝑓.

Figure 35. Signal acquisition method for Open QCM sensor.

This sensor has its software developed in Python programming language. Once

the measurement is started, it will only stop until the user indicates it. Once the

experiment is finished, all the data obtained are stored.

53
Miranda-Martínez

The measurement protocol is maintained except for a slight variation. As it is a

continuous measurement, the software visualizes the resonance frequency in

real-time. Thus, the user should consider that the desired resonance frequency

(without or with sample) has been measured once a stable signal is observed.

As the protocol states, the unsampled resonance frequency is obtained first.

When the signal stability is observed (and without stopping the process), the

sample is placed in the QCR. Again, a stable signal must be observed to

consider the resonance frequency localized. Upon completion, the generated

data are transferred to calculate the viscosity.

The cleaning protocol remains the same.

5.4. Volume variation with water

The first experiment was to observe the sensor's response when measuring

water samples by varying the sample volume between 30 and 70 µl. These

values were determined by observing that with 30 µl of water, it is possible to

completely cover the QCR area (without spaces exposed to air). On the other

hand, since no significant changes in viscosity were observed, the

measurements were concluded using 70 µl. Figure 36 shows the viscosity value

obtained (using equation 14), which ranges between 2.8 and 2.9 mPa·s

approximately.

With this, we can conclude that, by increasing the sample volume (completely

covering the crystal's surface), the sample's weight will have a negligible effect

on the viscosity measurement obtained by frequency shift.

54
Chapter 6

Figure 36. Viscosity measured by varying the volume of water samples.

5.5. Conventional fluids measurement

Distilled Water, Acetone, Alcohol, and different dilutions of mixtures of

glycerin, sugar, and salt were employed to study the measuring characteristics

with simple fluids. The dilutions used were 10, 20, and 30 wt% to increase the

density-viscosity of the fluid. An analytical balance (Discovery dv215,

OhausTM, Nänikon, Switzerland) was used to weigh the solute of the samples

and to obtain the density by weighing 1 mL of sample volume.

As a reference, a rotational viscometer (Searle-type, Alpha series, Fungilab,

Barcelona, Spain) was used. LCP adapter was employed; this allows viscosity

measures up to 2 Pa·s using 16 mL of the fluid. The viscosity results obtained

with the sensors were compared with those obtained with the rotational

viscometer.

In Table 4, the results for water, alcohol, and acetone are presented. Measured

∆𝑓 and the theoretical values of density and viscosity of the fluids are shown.

The three liquids have different viscosities, with acetone the less viscous and

isopropyl alcohol the most. It can be noted that the frequency difference

increases along with the density-viscosity of the fluid. The difference between

the theoretical viscosity value and the viscosity obtained by each sensor is large

55
Miranda-Martínez

and superior in the ViSQCT sensor; for example, the viscosity of water is

around 1 mPa·s (@ 20˚C), and the results show a value of 2.86 mPa·s for the

ViSQCT sensor and 2.29 mPa·s for the Open QCM sensor.

Water Alcohol Acetone

Isopropanol

Theoretical Density 1000 786 791

(mg/ml)

Theoretical Viscosity 1.00 2.10 0.32

(mPa·s)

∆𝑓 -3416 -4601 -2467

(Hz) ±62 ±218 ±179


ViSQCT sensor

Viscosity 2.86 6.60 1.88

(mPa·s) ±0.10 ±0.62 ±0.27

Viscosity difference 186 214 489

vs Theory (%)

∆𝑓 -3062 -3634 -1676

(Hz) ±54 ±196 ± 95


Open QCM

Viscosity 2.29 4.11 0.87

(mPa·s) ±0.08 ±0.44 ±0.10

Viscosity difference 129 96 171

vs Theory (%)

Table 4. Water, acetone and alcohol data and results.

Figures 37 and 38 show the values of ∆𝑓 and viscosity measured with both

sensors. The theoretical value of viscosity is also shown.

56
Chapter 6

Figure 37. ∆𝑓 measured for water, acetone and alcohol.

Figure 38. Viscosity measured for water, acetone and alcohol.

The results of each dilution are shown in Table 5. Figures 39, 40, and 41

illustrate each parameter measured. In this case, ∆𝑓 and viscosity were

measured with both sensors and ΔΓ only with the ViSQCT sensor; in addition,

the viscosity for each dilution was measured with the viscometer to compare it.

The dashed line represents the data obtained with the Open QCM sensor, and

the continuous line represents the ViSQCT sensor data; the value measured

with water is also shown in the figures. As expected, as viscosity increases on

each fluid, both ∆𝑓 and ΔΓ increases. There is a similar trend in ∆𝑓 increase

between both sensors, this is reflected in the viscosity results where an offset of

approximately 1.5 mPa·s is observed. The differences between the viscosity

57
Miranda-Martínez

obtained with the sensors and the obtained with the viscometer are significant ;

however, what is crucial for our purpose is the possibility of detecting viscosity

variations using ∆𝑓, which is shown in the results. The ΔΓ value obtained also

increased as viscosity increased. Its usefulness will be evaluated later since it

could be another parameter to help discriminate between samples.

Glycerin Sugar Salt

wt % 10% 20% 30% 10% 20% 30% 10% 20% 30%

Density (mg/ml) 1034 1064 1091 1045 1096 1139 1088 1145 1194

Viscosity (mPa·s) 1.11 1.50 2.00 1.16 1.66 2.94 1.14 1.33 1.40

∆𝑓 -4115 -4789 -5475 -4144 -4949 -6469 -4150 -4557 -5249

(Hz) ±34 ±20 ±106 ±46 ±34 ±65 ±64 ±149 ±52

ΔΓ 2248 2532 2901 2309 2649 3472 2293 2519 2726


ViSQCT sensor

(Hz) ±179 ±288 ±512 ±115 ±93 ±174 ±306 ±272 ±315

Viscosity 4.01 5.28 6.73 4.02 5.47 9.00 3.88 4.44 5.65

(mPa·s) ±0.06 ±0.04 ±0.26 ±0.08 ±0.07 ±0.18 ±0.12 ±0.29 ±0.11

Viscosity difference 261 252 236 247 230 206 240 234 304

vs Viscometer (%)

∆𝑓 -3367 -4091 -4702 -3432 -4296 -5398 -3502 -3855 -4317

(Hz) ±95 ±96 ±67 ±64 ±74 ±135 ±25 ±56 ±76
Open QCM

Viscosity 2.68 3.85 4.96 2.76 4.12 6.27 2.73 3.18 3.82

(mPa·s) ±0.15 ±0.18 ±0.14 ±0.10 ±0.14 ±0.30 ±0.04 ±0.09 ±0.13

Viscosity difference 142 157 148 138 148 113 142 139 173

vs Viscometer (%)

Table 5. Results for glycerin, sugar and salt.

58
Chapter 6

Figure 39. Comparison of ∆𝑓 measured for glycerin, sugar, and salt using both sensors.

Figure 40. Comparison of ∆Γ measured for glycerin, sugar, and salt using ViSQCT sensor.

Figure 41. Comparison of the viscosity obtained using both sensors and the viscometer (for
glycerin, sugar, and salt).

59
Miranda-Martínez

Figure 42 shows the ∆𝑓 measurement process (normalized) using water (black

line) and sugar 30% (blue line) samples with both sensors. In both cases, the

frequency drop is observed when the sample is added. Also, stability is noted

when measuring the resonance frequency. The Open QCM sensor has a more

stable curve when measuring sugar 30% (the sample with the highest viscosity

of the set).

Figure 42. Resonance frequency measurement for water and sugar 30% using: ViSQCT sensor
(left) and Open QCM sensor (right).

We can observe that there is a difference between the measured viscosities (each

sensor) and the reference viscosity (rotational viscometer),

At the end of the preliminary experiments, we can conclude that the sensor and

its methodology are valid for detecting viscosity changes of a fluid with a small

volume (50 µl) placed on the surface of the crystal. A second validation of this is

the comparison of the methodology using a commercial sensor with electronic

methods other than ours, obtaining similar results in the trend of the values as

the viscosity increased. Despite an offset between the two sensors (and a

notable difference between the two with the theoretical values), we can say that

both can respond with an increase in resonance frequency as the viscosity of the

sample increases.

60
Chapter 6

As mentioned in previous sections, the viscosity measured at high shear rates

can be different from that measured in steady share mode. The equation

obtained by Gordon and Kanazawa (Equation (14)) were obtained for an ideal

case without roughness. Considering all these points, the difference between

the sensors and the viscometer is comprehensible.

In chapter 7, tests using more complex fluids will be shown, whose response

will be vital to achieving the objectives proposed in this work.

61
Miranda-Martínez

6. Experimental Methodology

This chapter describes the measurement setup together with the experimental

samples. First, liquid phantoms were developed to simulate the viscous

properties of human fluids to test the sensor's capabilities in complex fluids.

Subsequently, measurements were performed with SF from several patients

provided by the Hospital Universitario La Paz (HULP). For this, approval was

obtained from the UPM ethics committee and the HULP ethics committee.

To explore further applications of the sensor, the response of the sensor was

observed when measuring the gelation of hydrogels using two different

gelation phenomena and varying the concentration.

The experimental setup is illustrated in Figure 43; the QCR is placed inside the

holder cell where the liquid sample is dropped. The volume of sample used is

50 µl since it allows to avoid the complete evaporation of the liquid.

Experiments were performed at room temperature.

Figure 43. Measurements set-up.

6.1. Phantoms

Chapter 2 mentioned that two fluids of interest in this project are SF and CSF.

The interest in both arises from studies showing that their viscosity change is

62
Chapter 6

associated with specific pathologies [20], [22], [24], [36]. Thus, for each case,

artificial fluids were developed to simulate the fluid's viscosity for both a

healthy and a pathological case. The experimentation with artificial

cerebrospinal fluid (aCSF) and artificial synovial fluid (aSF) expose an

interesting challenge for the sensor since each fluid has different behavior from

a rheological point of view. One presents a non-Newtonian behavior (aSF), and

the second shows a Newtonian behavior (aCSF).

6.1.1. aCSF

CSF is a complex fluid mainly composed of Na+ ,Cl− , and HCO−


3 with lesser

amounts of K + and Ca2+ [25], [26]. Some aCSF are reported in [96], [97], where

NaCl and NaHCO3 are the elements with higher concentrations. According to

this, healthy aCSF was developed with the concentrations listed in Table 6.

Albumin was used to increase viscosity in aCSF and simulate abnormal fluid

since it is the protein with a higher concentration in pathological CSF [98], [99].

The cases for viral meningitis (VM aCSF) and bacterial meningitis were

developed; also, two extra samples were created to have more information on

the detection abilities of the sensors.

NaCl 𝐍𝐚𝐇𝐂𝐎𝟑 Albumin

Fluid concentration concentration concentration

(mg/ml) (mg/ml) (mg/ml)

Healthy aCSF 7.25 2.18 0.0

VM aCSF 7.25 2.18 0.5

aCSF1 7.25 2.18 1.0

aCSF2 7.25 2.18 2.0

BM aCSF 7.25 2.18 3.0

Table 6. Artificial Cerebrospinal Fluids (aCSF) compositions.

63
Miranda-Martínez

6.1.2. aSF

SF is a mixture of plasma and HA, whose concentration determines the fluid's

viscoelastic properties. Arthritic diseases are associated with the reduction of

HA [21], [22], [24], [100]. For this reason, HA dilutions were made to generate

artificial SF (aSF) and emulate physical properties such as viscosity. In healthy

SF, the concentration is around 3.5 mg/ml, while in OA, the HA concentration

decrease to 1.3 mg/ml and in RA to approximately 0.84 mg/ml [101].

Six dilutions were made, one for healthy fluid two for abnormal fluid using the

aforementioned concentrations. Three extra dilutions were created to test the

sensor's detection capabilities. The mixtures were made with ultrapure water

and weighed the necessary amount of HA with an analytical balance. After

adding HA (Mw = 1.5 MDa; Acros Organics Inc.) into the water, gently stirring

was required. Finally, the sample is stored in the refrigerator for a few hours to

eliminate bubbles formed when mixing. Table 7 shows the compositions of the

synovial fluid phantom produced.

H. A.

Fluid concentration

(mg/ml)

Healthy aSF 3.5

aSF3 3.0

aSF2 2.0

OA aSF 1.3

aSF1 1.0

RA aSF 0.84

Table 7. Artificial Synovial Fluids (aSF) compositions.

64
Chapter 6

6.2. Synovial fluid samples

The Hospital Universitario La Paz (Madrid, Spain) provided synovial fluid

samples. These were the remnants of samples sent to the Emergency Laboratory

(in EDTA and lithium heparin containers). Thirty-three samples from different

patients were provided in EDTA containers, of which 28 were additionally

submitted in lithium heparin containers. The SFs were classified into two main

groups: inflammatory pathology (rheumatoid arthritis, gout, psoriatic arthritis,

etc.) and infectious pathology (septic arthritis and prosthetic infections).

In addition, a sample of healthy synovial fluid was obtained from Hospital

Clínico San Carlos (Madrid, Spain). It is essential to mention that the healthy SF

sample was delivered in a container without additives. In this case, the pre-

treatment consisted of centrifuging the sample at 3500 rpm for 10 minutes.

Subsequently, the supernatant of the sample was used for measurement.

A few samples are observed in Figure 44.

Figure 44. Synovial fluid samples.

6.3. Biopolymer-based hydrogels samples

The monitoring of hydrogel gelation was carried out with covalently

crosslinked mucin hydrogels and physically crosslinked alginate hydrogels.

With this, the gelation kinetics of two hydrogel systems will be explored. The

first is composed of two components formed via covalent bonds, and the

second is formed by alginate hydrogels (crosslinked through divalent ions).

65
Miranda-Martínez

For this type of experiment, it was necessary to use a smaller sample volume for

optimal detection and seal the QCR holder cell with parafilm paper to avoid

sample evaporation.

6.3.1. Covalently crosslinked mucin hydrogels

Muc-Tz and Muc-Nb were used at two concentrations: 15 and 25 mg/ml using

PBS. Then, a volume of 15 µl of each component was mixed (30 µl in total) and

added immediately to the crystal surface to start the measurement. The

duration of the experiment was 25 minutes to locate the frequency stability

zone (plateau-like zone).

6.3.2. Physically crosslinked alginate hydrogels

Alginate (60% G/M ratio) was stirred overnight at 15 mg/ml using saline

solution (154 mM NaCl). 𝐵𝑎𝐶𝑙2 and 𝐶𝑎𝐶𝑙2 were also diluted at 0.4 and 0.2 M

with NaCl. In the experiments, 20 µl of alginate was deposited on the crystal,

causing it to spread over the entire surface. Then, the resonance frequency of

the crystal was measured until it remained at a stable value. Once a stable

frequency was reached, 4 µl of 𝐵𝑎𝐶𝑙2 (or 𝐶𝑎𝐶𝑙2 ) was placed on the alginate to

start the gelation process. For this case, the measuring time was 15 minutes for

𝐵𝑎𝐶𝑙2 addition and 13 minutes for 𝐶𝑎𝐶𝑙2 addition.

66
Chapter 6

7. Results and Discussion

This chapter shows the results obtained from the experimental part of this

work. First, the results of the measurements with the CSF and SF phantoms are

detailed, then the analysis with real SF is shown. Finally, the results of the

experimentation with biopolymer-based hydrogels are illustrated. For all

graphs presented in this section, the shaded area denotes the standard

deviation as obtained from measurements of, at least, three independent

samples

7.1. Phantoms

7.1.1. aCSF

The aCSF analysis shows the sensor's response as the albumin concentration

increases, increasing fluid viscosity simulating CSF with a specific pathology, as

mentioned in previous sections. The results obtained are illustrated in Table 8.

The values of density and viscosity obtained with the rotational viscometer are

also shown.

Albumin concentration 0.0 0.5 1.0 2.0 3.0

(mg/ml) (aCSF) (VM aCSF) (BM aCSF)

Density (mg/ml) 1008 1010 1012 1013 1017

Viscosity (mPa·s) 1.01 1.02 1.03 1.05 1.06

∆𝒇 (Hz) -2957 -3112 -3215 -3474 -3587

±45 ±23 ±52 ±32 ±23

ΔΓ (Hz) 1466 1503 1548 1602 1688

±69 ±74 ±66 ±131 ±108

Viscosity measured 2.12 2.35 2.50 2.92 3.10

(mPa·s) ±0.06 ±0.03 ±0.08 ±0.05 ±0.04

Table 8. aCSF data and results obtained with the sensor.

67
Miranda-Martínez

The first parameters to be observed are ∆𝑓 and ΔΓ (Figure 45). As expected, ∆𝑓

decreased as the albumin concentration increased; in total, the frequency

dropped from around 600 Hz taking into account aCSF healthy (no albumin) to

BM aCSF (higher albumin concentration); a stable dispersion of the data is also

observed as the albumin concentration increases. On the other hand, ΔΓ

increased around 200 Hz with a more significant data dispersion than ∆𝑓.

The ∆𝑓 response makes it possible to distinguish between the measured

samples by having a threshold of about 100 Hz, thus distinguishing between

healthy aCSF, VM aCSF, and BM aCSF cases.

Figure 45. ∆𝑓 (black line) and ΔΓ (red line) obtained for aCSF samples.

Using ∆𝑓, we obtain the viscosity values by equation (14). The graph of the

measured viscosity as the albumin concentration increases is shown in Figure

46.

Again we can see that as the albumin concentration increases, the viscosity

increases. In this case, the measured viscosities range goes approximately from

2 to 3 mPa·s. The distinction between the three samples of interest is possible,

especially with VM aCSF, the sample with the highest viscosity. The dispersion

in each sample spans little more than 0.1 mPa·s (in general), which benefits the

possible detection of each sample.

68
Chapter 6

Figure 46. Viscosity obtained with the sensor using aCSF.

The last part of the aCSF study evaluates the viscosity measured with the

device with the viscosity obtained with the rotational viscometer. This can be

seen in Figure 47. It is clear that the resulting curve is almost straight, which is

expected for a Newtonian fluid. This can be beneficial in case of a calibration of

the system for this specific fluid is required. The equation of the straight line

(shown in red in the graph) corresponds to:

𝜂𝑄𝐶𝑅 = (19.5 · 𝜂𝑟𝑜𝑡 ) − 17.57, (19)

Where 𝜂𝑄𝐶𝑅 is the viscosity obtained with the sensor and 𝜂𝑟𝑜𝑡 is the viscosity

obtained with the rotational viscometer. The fit of the measured points to the

line presents an RMSE = 0.02.

In the case of aCSF, the viscosity obtained from the ∆𝑓 value is efficient for

distinguishing between samples with different viscosities. ΔΓ shows an

increase, which is related to the rise in the sample's viscosity. However, it

presents a high dispersion in the measured values, which indicates that its

independent use is inadequate for differentiation between samples.

69
Miranda-Martínez

Figure 47. Adjustment between the viscosity values measured with the sensor with the viscosity
of the rotational viscometer for aCSF samples.

7.1.2. aSF

The results obtained when measuring aSF, which has different physical

properties to aCSF as a non-Newtonian fluid, will now be presented. The

results obtained, together with the density and viscosity measured with the

rotational viscometer are presented below (Table 9).

Figure 48 shows the ∆𝑓 and ΔΓ values measured for each concentration of A.H.

It is clear that ∆𝑓 decrease and the ΔΓ increase as the A.H. increases; however,

they do not change linearly. This is due to the non-Newtonian fluid with

pseudoplastic behavior. The curves present a behavior that resembles an

exponential curve, with a sudden increase for low concentrations and a

progressive one at high concentrations.

The ∆𝑓 curve has a stable and low dispersion, while the ΔΓ curve has a

moderately higher and unsteady dispersion. For the frequency case, the

frequency decreased roughly 225 Hz from the sample with the lowest viscosity

(AR aSF) to the one with the highest viscosity (healthy aSF).

70
Chapter 6

H.A. 0.84 1.00 1.30 2.00 3.00 3.50

concentration (RA aSF) (OA aCF) (Healthy

(mg/ml) aSF)

Density 1007 1008 1009 1013 1022 1028

(mg/ml)

Viscosity 94 109 141 342 716 1133

(mPa·s)

∆𝒇 (Hz) -3004 -3074 -3138 -3166 -3201 -3228

±29 ±24 ±10 ±09 ±21 ±12

ΔΓ (Hz) 1722 1732 1776 1827 1825 1830

±22 ±15 ±28 ±07 ±15 ±34

Viscosity measured 2.19 2.29 2.39 2.42 2.46 2.48

(mPa·s) ±0.04 ±0.03 ±0.01 ±0.01 ±0.03 ±0.02

Table 9. aSF data and results obtained with the sensor.

When looking at the measurements of the fluids of interest, their differentiation

is remarkable, having a dispersion range of approximately 50 Hz for each

sample. On the other hand, ΔΓ increases by about 100 Hz, and dispersion of the

values compromises the differentiation between the samples of interest, having

values up to 70 Hz approximately.

The viscosity graph is shown in Figure 49. As the amount of A.H. increases, the

viscosity increases. As the frequency increases, the increase in viscosity starts

abruptly, and as the concentration increases, the increase in viscosity becomes

progressively almost linear. It is noticed that the viscosity increase starts at 2.2

mPa·s and ends at 2.5 mPa·s, i.e., about 0.3 mPa·s is the viscosity variation

measured with the sensor with these samples. Despite this reduced range, the

dispersion reaches 0.08 mPa·s, and the samples of interest can be identified.

71
Miranda-Martínez

Figure 48. ∆f (black line) and ΔΓ (red line) obtained for aSF samples.

Comparing the viscosity measured with the sensor with the viscosity measured

with the viscometer gives the curve shown in Figure 50. In this particular case,

the sensor's viscosity values are lower than those measured with the rotational

viscometer. Since aSF samples are a non-Newtonian fluid with pseudoplastic

behavior, the viscosity will decrease at the higher shear rate. The rotational

viscometer measures at 0.3 rpm; thus, the viscosity will be higher since the fluid

is measured with a low share rate. On the other hand, the crystals vibrate at 10

MHz which can be considered a high shear rate; thus, the viscosity will be

minor. Comparison between low share rate viscosities with high share rate

viscosities is beyond the scope of this work; however, the differentiation

between healthy aSF, OA aSF, and RA aSF is possible using this method.

In case a device calibration is required and using the rotational viscometer as a

reference, the curve that best fits the data is of the exponential type (with two

terms) shown in red in Figure 50. The equation representing this curve is:

𝜂𝑄𝐶𝑅 = 2.4 · 𝑒 (2.88𝐸−5)·𝜂𝑟𝑜𝑡 − 14.1 · 𝑒 (−0.04)·𝜂𝑟𝑜𝑡 , (20)

The fit of the measured points to the line presents an RMSE = 0.006.

72
Chapter 6

Figure 49. Viscosity obtained with the sensor using aSF.

Figure 50. Adjustment between the viscosity values measured with the sensor with the viscosity of the
rotational viscometer for aSF samples.

Despite the non-Newtonian fluid condition, identifying healthy aSF, OA aSF,

and RA aSF samples is possible with the methodology followed. ∆𝑓 is shown to

be the main parameter to make this distinction. On the other hand, ΔΓ is not

observed as a fundamental parameter but a secondary one that complements

the viscosity information, remembering that its increase is related to the rise in

viscosity, which is observed in these results.

It is clear that the sensor can discriminate pathological phantoms from healthy

phantoms efficiently. This leads us to speculate that, with real fluids, the

73
Miranda-Martínez

distinction between healthy and pathological fluids is uncomplicated; however,

the discrimination between pathologies could present difficulties. Differences in

glucose, hematocrit, cell, and protein levels in each sample obtained can be a

significant complication in differentiating between pathologies and even

between healthy and unhealthy fluid.

7.2. SF results

7.2.1. Inflammatory and infectious SF

When comparing the SF samples by classification (1 = inflammatory fluid, 2 =

infectious fluid, 3 = healthy fluid), differences can be seen between the first two

with type 3 (for both container tubes). However, in the absence of sufficient

healthy fluid samples, we cannot consider these results to be statistically

significant. Regardless, as a preliminary measure, it is optimistic about

observing what is expected in terms of a healthy SF showing a higher viscosity

than a pathological one. This will have to be worked on in the future.

Figures 51 - 53 show the boxplot and distribution of the measurements of each

parameter (∆𝑓, ΔΓ, and viscosity, respectively) between each type of

classification for the both types of tubes. Figures 54 - 59 show the distribution of

the measurements for each sample for each parameter in both type of tubes. In

all figures, it can be seen that the box on the far right constitutes the healthy SF

sample. Table 10 shows the average values of each measured parameter for

each classification and tube, together with their standard deviation.

The subsequent analysis will be carried out without considering the healthy SF

sample due to the scarcity of samples.

From the graphs, it can be seen that, for samples stored in lithium heparin gel

tubes, all three parameters measured had higher values than those held in

74
Chapter 6

EDTA tubes. For example, viscosity had a mean value of 3.46 mPa·s for the

EDTA tube samples, and for the samples contained in lithium heparin tubes,

the mean value was 3.74 mPa·s.

Figure 51. ∆𝑓 boxplots. Left: EDTA tube; right: Lithium heparin tube

Figure 52. ΔΓ boxplots. Left: EDTA tube; right: Lithium heparin tube

Figure 53. Viscosity boxplots. Left: EDTA tube; right: Lithium heparin tube

75
Miranda-Martínez

Figure 54. Boxplots per sample (EDTA tube) for ∆𝑓 measurements.

Figure 55. Boxplots per sample (EDTA tube) for ΔΓ measurements.

76
Chapter 6

Figure 56. Boxplots per sample (EDTA tube) for viscosity values.

Figure 57. Boxplots per sample (Lithium heparin tube) for ∆f measurements.

77
Miranda-Martínez

Figure 58. Boxplots per sample (Lithium heparin tube) for ΔΓ measurements.

Figure 59. Boxplots per sample (Lithium heparin tube) for viscosity values.

Disregarding the healthy SF sample, a study was conducted using the Mann-

Whitney-U statistical test to calculate the p-value. SPSS software was employed

for this purpose. The results are shown in Table 10. Other values such as WBC,

78
Chapter 6

neutrophil percentage, protein, and glucose are also detailed in the table. The

hospital provided these data.

There are significant differences (p < 0.05) in ∆𝑓 and ΔΓ between inflammatory

SF and infectious SF for the lithium heparin tubes. However, no statistically

significant differences were observed in the measurements of ∆𝑓 in the EDTA

tubes, and viscosity for both containers. On the other hand, the WBC value

shows significant differences in distinguishing the type of SF in both tubes.

Inflammatory Infectious p-value

Age (yr) 55.52 ± 27.53 72.75 ± 15.27 0.08

WBC (/𝑚𝑚3 ) 9060 ± 12526 52575.62 ± 75126.19 0.02

Neutrophils (%) 57.28 ± 36.39 85.50 ± 12.43 0.02

Glucose (mg/dl) 99.23 ± 32.11 64.37 ± 35.97 0.05


EDTA

Proteins (g/dl) 3.87 ± 0.82 4.15 ± 0.49 0.23

∆𝑓 (Hz) -3665.36 ± 135.34 -3675.87 ± 104.57 0.25

ΔΓ (Hz) 1787.47 ± 66.97 1810.47 ± 53.34 0.04

𝜂 (mPa·s) 3.46 ± 0.21 3.43 ± 0.30 0.11

Age (yr) 64.66 ± 18.96 71.85 ± 16.27 0.29

WBC (/𝑚𝑚3 ) 9032.76 ± 13478.73 57789.28 ± 79560.83 0.03


Lithium heparin gel

Neutrophils (%) 63.11 ± 36.80 84.00 ± 12.62 0.16

Glucose (mg/dl) 99.23 ± 32.11 59.57 ± 35.98 0.01

Proteins (g/dl) 3.87 ± 0.82 4.11 ± 0.52 0.29

∆𝑓 (Hz) -3775.40 ± 106.55 -3812.91 ± 109.05 0.03

ΔΓ (Hz) 1861.21 ± 95.89 1908.10 ± 72.09 < 0.01

𝜂 (mPa·s) 3.76 ± 0.31 3.67 ± 0.18 0.13

Table 10. Mean value and p-value per parameter for each classification and container type

The predictive abilities of each parameter are shown in the Receiver Operating
Characteristic (ROC curve) in Figure 60 and Table 11, which illustrate the area's
value under the ROC curve (AUC), Confidence Interval (CI), and Standard

79
Miranda-Martínez

Error (SE). Also shown for reference are the WBC, serum procalcitonin (PCT),
and SF PCT parameters obtained in a different study [102].
In Figure 60 we can see that the viscosity calculation obtained does not
discriminate well the infectious SF. On the other hand, ∆𝑓 and ΔΓ had a better
result in the samples contained in lithium heparin, although they do not
become a test that stands out.
AUC CI 95% SE
Talebi-Taher
WBC (/𝑚𝑚3 ) 1.00 1.00 – 1.00 0.00
[102]
PCT serum 0.82 0.71 – 0.92 0.05

PCT SF 0.65 0.51 – 0.78 0.06

WBC (/𝑚𝑚3 ) 0.78 0.60 – 0.97 0.09

Neutrophils (%) 0.76 0.58 – 0.94 0.09

Glucose (mg/dl) 0.26 0.03 – 0.49 0.12


EDTA

Proteins (g/dl) 0.64 0.44 -0.85 0.10

∆𝑓 (Hz) 0.55 0.46 – 0.65 0.04

ΔΓ (Hz) 0.60 0.51 – 0.69 0.04

𝜂 (mPa·s) 0.42 0.31 – 0.52 0.05

WBC (/𝑚𝑚3 ) 0.80 0.61 – 0.99 0.09

Neutrophils (%) 0.68 0.46 – 0.91 0.11


Lithium heparin gel

Glucose (mg/dl) 0.20 0.00 – 0.43 0.11

Proteins (g/dl) 0.62 0.39 – 0.85 0.11

∆𝑓 (Hz) 0.61 0.51 – 0.72 0.05

ΔΓ (Hz) 0.65 0.55 – 0.74 0.04

𝜂 (mPa·s) 0.42 0.33 – 0.50 0.04

Table 11. Area under the ROC curve of the parameters as predictors for infectious fluid for both
tubes.

80
Chapter 6

Figure 60. ROC curve for parameters measured with the sensor for: SF in EDTA tubes (left)
and SF in lithium heparin tubes (right).

The obtained parameters showed promise in samples stored in tubes with

lithium heparin. However, for SF held in EDTA, the data were not helpful for

discrimination between infectious and inflammatory SF. This may be due to the

change generated by the type of tube in the physical properties of the sample,

with samples in EDTA being less viscous. In [102], the study shows that

procalcitonin (PCT) is used as a marker to discriminate infectious SF. The study

shows that the WBC value is the most accurate when distinguishing infectious

SF (AUC = 1). When evaluating the value of PCT in serum and PCT in SF, they

show that PCT in serum was better (AUC = 0.82) than PCT in SF (AUC = 0.65).

This last value is comparable with the ∆𝑓 (AUC = 0.61) and ΔΓ (AUC = 0.65)

obtained in this work (lithium heparin tubes). Neutrophils, glucose, and

proteins showed no significant relevance in distinguishing between the two

fluids.

7.2.2. Comparison between SF pathologies

On the other hand, samples with similar pathologies were compared to observe

cases where significant differences were obtained and, with this, to discriminate

between diseases. The selected conditions were: psoriatic arthritis, rheumatoid

arthritis, infectious SF, and monoarthritis, as these were samples from two

81
Miranda-Martínez

different patients. The results are shown below. Figures 61 - 63 show the points

obtained for ∆𝑓, ΔΓ, and viscosity, respectively. The results for samples

contained in EDTA tubes are on the left side, and on the right side are the

results for samples collected in lithium heparin gel tubes. Table 12 includes the

p-value obtained between each sample.

Figure 61. Comparison between obtained ∆𝑓 for specific SF conditions.

Figure 62. Comparison between obtained ΔΓ for specific SF conditions.

Figure 63. Comparison between obtained viscosity for specific SF conditions.

82
Chapter 6

There are some cases where there are significant differences (p < 0.05) between

the selected pathologies. There are few coincidences of significant differences

for the same cases in both SF containers, highlighting that, among the instances

of RA-infection and RA-monoarthritis, ∆𝑓 and ΔΓ had a p-value < 0.05. In

addition, ∆𝑓 obtained significant differences when evaluating samples with RA

in all cases and both tubes. This indicates that, for the RA case, differentiation

between SF samples might be possible measuring ∆𝑓; however, the number of

samples evaluated is reduced to draw early conclusions.

EDTA Lithium heparin

∆𝒇 ΔΓ Viscosity ∆𝒇 ΔΓ Viscosity

P. arthritis-RA < 0.001 0.104 < 0.001 < 0.001 0.031 0.910

P. arthritis-infection 0.036 0.307 0.279 0.946 0.114 0.114

P. arthritis-monoarthritis 0.865 0.023 0.162 < 0.001 0.004 < 0.001

RA-infection 0.002 0.002 0.036 < 0.001 0.002 0.744

RA-monoarthritis < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.825

Infection- monoarthritis 0.002 0.487 0.018 0.003 0.055 < 0.001

Table 12. p-value calculation employing Tukey HSD for specific diseases.

7.2.3. Artificial Neural Networks for the classification of inflammatory

and infectious SF

As an alternative to increasing the sensor's capabilities, we have tested the use

of Artificial Neural Networks (ANN) to train them with the data obtained and

achieve the classification between inflammatory and infectious SF samples. For

this purpose, we generated the following algorithm (Figure 64), whose variable

parameters were the number of epochs (100, 200, 300) and the hidden layers (1

and 2). Parameters such as the optimizer, activation function, biases, etc., were

left constant since it is beyond the scope of this work to go into this topic in

more detail.

83
Miranda-Martínez

Figure 64. ANN algorithm for SF classification.

The ∆𝑓, ΔΓ, and viscosity values are used as inputs to the network, and the two

SF conditions provided by the hospital (inflammatory and infectious) are used

as outputs. To be used optimally, they are normalized to locate the data in a

range of values between 0 and 1. The data are then randomly selected for the

training, validation, and testing phases, with the training phase requiring the

most significant number of data. Later, when calculating the accuracy, the

"testing data" isolated at this stage will be used exclusively for testing the

algorithm.

When defining the neural network, we set the following:

• Three input neurons (one for each input parameter; Relu activation

function),

84
Chapter 6

• Two output neurons (classification; Softmax activation function),

• One or two hidden layers (each with 50 outputs; Relu activation

function),

• Number of training epochs and,

• Adam-type optimizer.

After training, the algorithm tests the generated classification using the data set

aside for this purpose. In this way, it calculates the accuracy of the algorithm.

Finally, the confusion matrix is obtained, where the performance of the

classification is observed.

The accuracy values obtained for each ANN configuration are shown in Table

13.

More specific details of the ANN and the loss and accuracy curves for each

training can be found in the appendix of this work.

EDTA Lithium

heparin

Hidden Layers: 1 0.774 0.921

Epochs: 100

Hidden Layers: 1 0.834 0.937

Epochs: 200

Hidden Layers: 1 0.885 0.955

Epochs: 300

Hidden Layers: 2 0.830 0.928

Epochs: 100

Hidden Layers: 2 0.896 0.979

Epochs: 200

Hidden Layers: 2 0.891 0.983

Epochs: 300
Table 13. Accuracy obtained for each test.

The results obtained with both tubes were compared, and it was observed that

using the samples stored in lithium heparin gave a higher accuracy in the

85
Miranda-Martínez

classification algorithm. The highest accuracy (accuracy = 98.3%) was obtained

using two hidden layers and 300 training epochs and the samples contained in

lithium heparin tubes. The lowest accuracy (accuracy = 77.4%) occurred when

using samples stored in EDTA tubes, 1 hidden layer, and 100 training epochs.

The confusion matrices are shown in Figures 65 and 66, the first showing the

matrices for the case of SF from EDTA tubes, and the second for SF samples

from lithium heparin tubes. For the best case, it is observed that it correctly

classified 774 samples and incorrectly 13. For the worst case, it correctly

classified 577 samples and poorly 168.

86
Chapter 6

Figure 65. Confusion matrices obtained by ANN for SF samples contained in EDTA tubes.

87
Miranda-Martínez

Figure 66. Confusion matrices obtained by ANN for SF samples contained in lithium heparin
tubes.

7.3. Biopolymer-based hydrogels results

7.3.1. Covalently crosslinked hydrogels

In testing the sensor's capabilities in measuring the gelling process of a

hydrogel system composed of two components formed via covalent bonds, we

obtained the following results.

88
Chapter 6

The measurements show a change in resonance frequency of the sensor

approximately 5 minutes after mixing the two components (Figures 67 and 68),

irrespective of the concentrations. The sensor's resonance frequency continued

to drop until reaching a plateau-like state in approximately 25 minutes for

higher concentration. After 25 minutes of gelation, the frequency drop was

clearly high for the more concentrated Muc-gels system.

Speaking of ΔΓ, this parameter did not have a significant change for the lower

concentration Muc-gel. The values remained close to zero during the gelation

process and grew around 100 Hz. On the other hand, growth was observed

after 2.5 minutes for the highest concentration, stabilizing at around 600 Hz. It

can be said that both ∆𝑓 and ΔΓ underwent a minimum change for the Muc-gel

concentrated at 15 mg/ml and, for the Muc-gel at 25 mg/ml, both parameters

experienced a more significant increase. Such changes in both parameters could

be correlated with the physical properties of each material.

Figure 67. Time-dependent evaluation of ∆f (black line) and ΔΓ (red line) for 15 mg/ml Muc-
gels.

89
Miranda-Martínez

Figure 68. Time-dependent evaluation of ∆f (black line) and ΔΓ (red line) for 25 mg/ml Muc-
gels.

These results clearly demonstrate the potential to use QCR measurement to

validate gelation events in covalently crosslinked hydrogel systems easily and

follow the gelling kinetics and assess differences in the mechanical properties of

the gelled system due to polymer concentration.

7.3.2. Physically crosslinked alginate hydrogels

We then tested whether QCR could also measure the gelling kinetics of alginate

hydrogels, crosslinked through divalent ions.

First, Figure 69 shows the measurement of 20 µl of alginate solution (1.5%,

wt/v) loaded on the QCR before exposure to calcium or barium and its gelation.

The curve shows the gelation process until the frequency stabilizes after

approximately 10 minutes.

90
Chapter 6

Figure 69. ∆f (black line) and ΔΓ (red line) change after placing an alginate solution (15
mg/ml) on the sensor.

The addition of a similar volume of NaCl solution (0.4 M) to alginate caused a

frequency increase (Figure 70), indicating that the samples were diluted by the

addition of the solution and formed a less viscous fluid. Indeed sodium, which

is used as a counterion to alginate, does not induce its gelation. We can also

observe that, when adding sodium to the alginate, the frequency takes

approximately 2 minutes to reach equilibrium, so we consider this time a

stabilization period caused by factors such as the damping produced when

changing the physical properties of the sample.

Figure 70. ∆f (black line) and ΔΓ (red line) change likely caused by a dilution effect following
exposure of the alginate to a solution of NaCl (0.4 M).

Once the plateau with alginate was reached, the gelation started by adding a

small volume (4 µl) of 𝐵𝑎𝐶𝑙2 or 𝐶𝑎𝐶𝑙2 solutions. When adding the divalent ions,

91
Miranda-Martínez

the frequency of the QCR dropped, reflecting the increases in the viscous

response of the material. The frequency shift values shown in Figure 71 were

calculated from average frequency values from 12 minutes from adding barium

ions and from 10 and 6 minutes after adding calcium at 0.4 M and 0.2 M,

respectively. The frequency drop was sensitive to two parameters known to

impact alginate gelation: the type of ion used and the molar ratio of divalent

ions to alginate.

Figure 71. Comparison of Δf plateau-like stage for the four cases.

In the following graphics, the kinetics of each gelation are shown. Barium ions

led to a higher frequency drop than calcium at both concentrations (Figures 72 -

75). Decreasing the concentration of each ion by half also reduced the frequency

drop. The concentration of ionic crosslinker affects how many of such

crosslinking points are occupied on the alginate, which would directly affect the

resulting gelling kinetics and mechanical properties. These results indicate that

the QCR can indeed sense the ionic crosslinking of alginate into a hydrogel.

Barium ions (0.195 nm) have been reported to crosslink alginate into more

stable gels than calcium, owing to its larger size than calcium ions (0.097 nm).

Barium ions are a tighter fit within the alginate egg-box configuration that it

adopts around such divalent ions [103]. Thus, stiffer gels can be obtained by

crosslinking alginate solutions with barium ions compared to calcium ions at

the same concentration.

92
Chapter 6

Figure 72. ∆f (black line) and ΔΓ (red line) response for alginate gel formation using 𝐵𝑎𝐶𝑙2 (0.4
M).

Figure 73. ∆f (black line) and ΔΓ (red line) response for alginate gel formation using 𝐵𝑎𝐶𝑙2 (0.2
M).

Figure 74. ∆f (black line) and ΔΓ (red line) response for alginate gel formation using 𝐶𝑎𝐶𝑙2 (0.4
M).

93
Miranda-Martínez

Figure 75. ∆f (black line) and ΔΓ (red line) response for alginate gel formation using 𝐶𝑎𝐶𝑙2 (0.2
M).

There are also clear differences in the gelation kinetics of the gels. A sharp

initial decrease in frequency immediately after exposure to the divalent ions for

𝐵𝑎𝐶𝑙2 and 𝐶𝑎𝐶𝑙2 at the highest concentrations could result from mechanical

strain onto the crystal due to the sudden gelation of the alginate solution

(Figures 72, 74). This is also observed for 𝐵𝑎𝐶𝑙2 at the lowest concentration

(Figure 73), indicating that Barium generates a strong and impulsive

crosslinking with both concentrations. The lower concentration of 𝐶𝑎𝐶𝑙2 did not

induce this initial drop (Figure 75), perhaps due to the lower crosslinking extent

and strength compared to the other conditions. To assess whether the initial

sharp decrease in frequency could be due to the development of the ionic

crosslinking within the gel, we estimated the diffusion times of both ions. For

𝐶𝑎𝐶𝑙2, considering a diffusion constant D = 0.79 [104] and a thickness = 0.502

mm, the diffusion time was 2.7 min. For 𝐵𝑎𝐶𝑙2 , maintaining the thickness and D

= 0.84 [104], the diffusion time results in 2.5 min. These diffusion times are

within the timescale of these sharp frequency increases that took about one

minute to develop.

Following the initial drop in frequency, a progressive evolution than

stabilisation was seen, which could be due to further diffusion of the ions into

94
Chapter 6

the gel. It should also be considered that QCRs measure in the region closest to

the crystal surface. Recalling, the penetration depth is 178 nm for a QCR with 𝑓0

= 10 MHz in water. It is, therefore, possible to consider a slower stabilisation

time in this region.

Figure 76 shows the time response of the complete experiment, from alginate

alone to gelation with the different ions.

Figure 76. Kinetics of the alginate gelation process with all the cases evaluated.

95
Miranda-Martínez

8. Conclusions and Future Work

8.1. Conclusions

A method is proposed to characterize fluid viscosity (mainly from a biological

source) using a small sample volume (tens of microliters). Phantoms of SF and

CSF were developed and measured, and the results show that distinction

between fluids with different viscosity could be made. The ViSQCT sensor, at

least when being applied to phantoms fluids, can distinguish between healthy

aSF and pathological aSF. Furthermore, the sensor distinguished between the

two pathological phantoms of each fluid type. As aSF is a non-Newtonian fluid,

the viscosity results obtained with the sensor had a minor increase than those

obtained with the reference viscometer. The results obtained with aCSF show

the possibility of detecting the small viscosity changes between the healthy

aCSF, VM aCSF, and BM aCSF. Calibration curves were suggested for each

phantom to adjust the sensor data with the rotational viscometer information.

Interesting results were obtained when comparing the SF samples with specific

diseases and the healthy fluid sample, as differentiation is possible, at least

from the healthy SF and SF cases with monoarthritis and RA. However,

statistically significant results are not available due to the lack of considerable

samples. On the other hand, when comparing the two classifications of SF

(inflammatory and infectious), it isn't easy to distinguish between them when

looking at their distribution. Nevertheless, it was shown that there are

significant differences in viscosity measured in samples stored in lithium

heparin tubes.

As the distinction between classifications by direct comparison of the measured

parameters was not clear, the use of ANN was proposed, which showed that,

96
Chapter 6

with the help of this technology, it is possible to achieve an efficiency of 98.3%

when classifying between inflammatory and infectious SF.

The sensor demonstrates that can be used to follow the gelling process and

compare the resulting mechanical properties of hydrogels. Using two hydrogel

systems with covalent and physical ionic crosslinking, we demonstrate the

versatility of the approach.

The kinetic of the frequency drop, and the frequency drop at equilibrium, can

be used to compare hydrogel systems and indicate their final mechanical

properties. Such a sensor could be used to assess (quickly) whether crosslinking

has occurred and compare between strategies immediately. Overall this work

provides the proof of concept for this class of sensors to be used as hydrogel

formation monitors.

Finally, it is proven that developing a low-cost, portable sensor is possible by

using QCRs. The results obtained with the device (and its associated

methodology) show its great functionality in biomedical applications, both in

the study of human fluids and the characterization of materials such as

hydrogels. Nevertheless, the device deserves further development to become an

instrument that can assist physicians in analysis (diagnosis inclusive) and a

complete laboratory tool for monitoring mechanical properties in hydrogel

formation.

8.2. Future work

The following developments are proposed for future work:

- The prototype can be reduced in size by including the signal generation and

analog-digital communication modules on the board. Doing without batteries

would help to achieve this goal. Including wireless communication between the

computer and the sensor would improve the sensor's capabilities by allowing it

97
Miranda-Martínez

to be placed in spaces such as a work hood or incubator for biological

experimentation.

-Improve the system by adding the possibility of dynamic measurements using

a microfluidic system, which should include a temperature sensor, which will

expand the opportunities for experimentation.

-Explore experimentation by the biofunctionalization of the QCR. As with the

previous point, this will open the door to new projects.

-Increase the number of real samples measured to have, on the one hand, a

larger number of data to analyze, and on the other hand, to generate a more

extensive database to help ANN training.

-Getting real samples of CSF or pleural effusions will open new lines of

experimentation that could extend the sensor's functionality.

-It is necessary to carry out a quantitative comparison between the proposed

method and a rheology measurement for its validation in hydrogel

characterization.

-Improve methodology when measuring hydrogels. The high viscosity of the

measured samples makes it difficult to place the precise sample volume by

pipetting. Using better instrumentation to control the volume deposited on the

glass will improve experimentation with these materials.

-Further study of the relationship between measurements obtained with

rheological measurements.

98
Annex

9. Annex

This section shows in more detail the main characteristics of the ANN network

(Table 14). Subsequently (Figures 77 - 100), each trained configuration's

accuracy and loss curves are presented.

Parameter Features

Input Layer Neurons: 3

Activation function: Relu

Hidden Layers 1 or 2 hidden layers

Neurons: 50

Activation function: Relu

Output Layer Neurons: 2

Activation function: Softmax

Training Epochs 100, 200, 300

Optimizer Type Adam

Table 14. Features of the ANN.

Figure 77.Variation of accuracy throughout training with one layer and 100 epochs using SF
stored in tubes with EDTA.

99
Miranda-Martínez

Figure 78. Variation of losses throughout training with one layer and 100 epochs using SF
stored in tubes with EDTA.

Figure 79. Variation of accuracy throughout training with one layer and 200 epochs using SF
stored in tubes with EDTA.

100
Annex

Figure 80.Variation of losses throughout training with one layer and 200 epochs using SF
stored in tubes with EDTA.

Figure 81. Variation of accuracy throughout training with one layer and 300 epochs using SF
stored in tubes with EDTA.

Figure 82. Variation of losses throughout training with one layer and 300 epochs using SF
stored in tubes with EDTA.

101
Miranda-Martínez

Figure 83. Variation of accuracy throughout training with two layers and 100 epochs using SF
stored in tubes with EDTA.

Figure 84. Variation of losses throughout training with two layers and 100 epochs using SF
stored in tubes with EDTA.

Figure 85. Variation of accuracy throughout training with two layers and 200 epochs using SF
stored in tubes with EDTA.

102
Annex

Figure 86. Variation of losses throughout training with two layers and 200 epochs using SF
stored in tubes with EDTA.

Figure 87. Variation of accuracy throughout training with two layers and 300 epochs using SF
stored in tubes with EDTA.

Figure 88. Variation of losses throughout training with two layers and 300 epochs using SF
stored in tubes with EDTA.

103
Miranda-Martínez

Figure 89. Variation of accuracy throughout training with one layer and 100 epochs using SF
stored in tubes with lithium heparin.

Figure 90. Variation of losses throughout training with one layer and 100 epochs using SF
stored in tubes with lithium heparin.

104
Annex

Figure 91. Variation of accuracy throughout training with one layer and 200 epochs using SF
stored in tubes with lithium heparin.

Figure 92. Variation of losses throughout training with one layer and 200 epochs using SF
stored in tubes with lithium heparin.

Figure 93. Variation of accuracy throughout training with one layer and 300 epochs using SF
stored in tubes with lithium heparin.

105
Miranda-Martínez

Figure 94. Variation of losses throughout training with one layer and 300 epochs using SF
stored in tubes with lithium heparin.

Figure 95. Variation of accuracy throughout training with two layers and 100 epochs using SF
stored in tubes with lithium heparin.

Figure 96. Variation of losses throughout training with two layers and 100 epochs using SF
stored in tubes with lithium heparin.

106
Annex

Figure 97. Variation of accuracy throughout training with two layers and 200 epochs using SF
stored in tubes with lithium heparin.

Figure 98. Variation of losses throughout training with two layers and 200 epochs using SF
stored in tubes with lithium heparin.

Figure 99. Variation of accuracy throughout training with two layers and 300 epochs using SF
stored in tubes with lithium heparin.

107
Miranda-Martínez

Figure 100. Variation of losses throughout training with two layers and 300 epochs using SF
stored in tubes with lithium heparin.

108
References

References

[1] C. K. O’Sullivan and G. G. Guilbault, “Commercial quartz crystal

microbalances - Theory and applications,” Biosensors and Bioelectronics,

vol. 14, no. 8–9, pp. 663–670, 1999, doi: 10.1016/S0956-5663(99)00040-8.

[2] D. Johannsmann, “The quartz crystal microbalance in soft matter

research,” Soft and Biological Matter, pp. 191–204, 2015.

[3] G. Sauerbrey, “Verwendung von Schwingquarzen zur Wägung dünner

Schichten und zur Mikrowägung,” Zeitschrift für physik, vol. 155, no. 2, pp.

206–222, 1959.

[4] K. Keiji Kanazawa and J. G. Gordon, “The oscillation frequency of a

quartz resonator in contact with liquid,” Analytica Chimica Acta, vol. 175,

pp. 99–105, 1985, doi: https://doi.org/10.1016/S0003-2670(00)82721-X.

[5] W. Hai et al., “Specific Recognition of Human Influenza Virus with

PEDOT Bearing Sialic Acid-Terminated Trisaccharides,” ACS Applied

Materials & Interfaces, vol. 9, no. 16, pp. 14162–14170, Apr. 2017, doi:

10.1021/acsami.7b02523.

[6] R. Wang, L. Wang, Z. T. Callaway, H. Lu, T. J. Huang, and Y. Li, “A

nanowell-based QCM aptasensor for rapid and sensitive detection of

avian influenza virus,” Sensors and Actuators B: Chemical, vol. 240, pp. 934–

940, 2017, doi: https://doi.org/10.1016/j.snb.2016.09.067.

[7] H. J. Lim, T. Saha, B. T. Tey, W. S. Tan, and C. W. Ooi, “Quartz crystal

microbalance-based biosensors as rapid diagnostic devices for infectious

diseases,” Biosensors and Bioelectronics, vol. 168, no. June, p. 112513, 2020,

doi: 10.1016/j.bios.2020.112513.

109
Miranda-Martínez

[8] N. Wangmaung, S. Chomean, C. Promptmas, S. Mas-oodi, D. Tanyong,

and W. Ittarat, “Silver quartz crystal microbalance for differential

diagnosis of Plasmodium falciparum and Plasmodium vivax in single

and mixed infection,” Biosensors and Bioelectronics, vol. 62, pp. 295–301,

2014, doi: https://doi.org/10.1016/j.bios.2014.06.052.

[9] T. N. Ly, S. Park, and S. J. Park, “Detection of HIV-1 antigen by quartz

crystal microbalance using gold nanoparticles,” Sensors and Actuators B:

Chemical, vol. 237, pp. 452–458, 2016, doi:

https://doi.org/10.1016/j.snb.2016.06.112.

[10] L. A. Hiatt and D. E. Cliffel, “Real-time recognition of Mycobacterium

tuberculosis and lipoarabinomannan using the quartz crystal

microbalance,” Sensors and Actuators B: Chemical, vol. 174, pp. 245–252,

2012, doi: https://doi.org/10.1016/j.snb.2012.06.095.

[11] F. He and L. Zhang, “Rapid diagnosis of M. tuberculosis using a

piezoelectric immunosensor,” Analytical sciences, vol. 18, no. 4, pp. 397–

401, 2002.

[12] F. He, L. Zhang, J. Zhao, B. Hu, and J. Lei, “A TSM immunosensor for

detection of M. tuberculosis with a new membrane material,” Sensors and

Actuators B: Chemical, vol. 85, no. 3, pp. 284–290, 2002, doi:

https://doi.org/10.1016/S0925-4005(02)00144-2.

[13] S. S. Hwang et al., “Detection of amyloid β oligomers toward early

diagnosis of Alzheimer’s disease,” Analytical Biochemistry, vol. 566, pp.

40–45, 2019, doi: https://doi.org/10.1016/j.ab.2018.09.011.

[14] M. Yılmaz, M. Bakhshpour, I. Göktürk, A. K. Pişkin, and A. Denizli,

“Quartz Crystal Microbalance (QCM) Based Biosensor Functionalized by

110
References

HER2/neu Antibody for Breast Cancer Cell Detection,” Chemosensors , vol.

9, no. 4. 2021. doi: 10.3390/chemosensors9040080.

[15] S. Liao, P. Ye, C. Chen, J. Zhang, L. Xu, and F. Tan, “Comparing of

Frequency Shift and Impedance Analysis Method Based on QCM Sensor

for Measuring the Blood Viscosity,” Sensors , vol. 22, no. 10. 2022. doi:

10.3390/s22103804.

[16] G. E. Leblanc, R. A. Secco, and M. Kostic, “Viscosity measurement,” in

The Measurement, Instrumentation, and Sensors, CRC Press, 1999.

[17] G. Schramm, “A Practical Approach to Rheology and Rheometry,”

Rheology, p. 291, 1994, [Online]. Available:

http://www.polymer.cn/bbs/File/UserFiles/UpLoad/200904010309415s.pdf

[18] A. L. Mundt and K. Shanahan, “Graff’s textbook of routine urinalysis and

body fluids. Print book: English.” Philadelphia: Wolters

Kluwer/Lippincott Williams & Wilkins Health, 2010.

[19] J. Damiano and T. Bardin, “Synovial fluid,” in EMC-Rhumatologie-

Orthopedie, vol. 1, no. 1, 2004, pp. 2–16. doi: 10.1016/j.emcrho.2003.11.002.

[20] S. R. Brannan and D. A. Jerrard, “Synovial fluid analysis,” Journal of

Emergency Medicine, vol. 30, no. 3, pp. 331–339, Apr. 2006, doi:

10.1016/j.jemermed.2005.05.029.

[21] A. Martínez-Castillo, C. Núñez, and J. Cabiedes, “Synovial fluid

analysis,” Reumatología Clínica (English Edition), vol. 6, no. 6, pp. 316–321,

2010, doi: https://doi.org/10.1016/S2173-5743(10)70074-5.

[22] C. T. STAFFORD, W. NIEDERMEIER, H. L. HOLLEY, and W. PIGMAN,

“STUDIES ON THE CONCENTRATION AND INTRINSIC VISCOSITY

OF HYALURONIC ACID IN SYNOVIAL FLUIDS OF PATIENTS WITH

111
Miranda-Martínez

RHEUMATIC DISEASES.,” Ann Rheum Dis, vol. 23, no. 2, pp. 152–157,

1964, doi: 10.1136/ard.23.2.152.

[23] C. Rojas, “Estudio del líquido sinovial,” in Guía de procedimientos en

reumatología, Bogotá, Colombia: Asociación Colombiana de Reumatología,

2012, pp. 41–47.

[24] S. G. West, Rheumatology Secrets, 3rd ed. Philadeplhia: Elsevier, 2014.

Accessed: Nov. 11, 2020. [Online]. Available:

https://www.elsevier.com/books/rheumatology-secrets/west/978-0-323-

03700-6

[25] R. Spector, S. Robert Snodgrass, and C. E. Johanson, “A balanced view of

the cerebrospinal fluid composition and functions: Focus on adult

humans,” Experimental Neurology, vol. 273, pp. 57–68, 2015, doi:

https://doi.org/10.1016/j.expneurol.2015.07.027.

[26] L. Sakka, G. Coll, and J. Chazal, “Anatomy and physiology of

cerebrospinal fluid,” European Annals of Otorhinolaryngology, Head and

Neck Diseases, vol. 128, no. 6, pp. 309–316, 2011, doi:

https://doi.org/10.1016/j.anorl.2011.03.002.

[27] N. Hirsch, “Cerebrospinal fluid and its physiology,” Anaesthesia &

Intensive Care Medicine, vol. 14, no. 9, pp. 379–380, Sep. 2013, doi:

10.1016/j.mpaic.2013.06.001.

[28] B. L. C. Wright, J. T. F. Lai, and A. J. Sinclair, “Cerebrospinal fluid and

lumbar puncture: A practical review,” Journal of Neurology, vol. 259, no. 8,

pp. 1530–1545, 2012, doi: 10.1007/s00415-012-6413-x.

112
References

[29] F. Deisenhammer et al., “Guidelines on routine cerebrospinal fluid

analysis. Report from an EFNS task force,” European Journal of Neurology,

vol. 13, no. 9, pp. 913–922, 2006, doi: 10.1111/j.1468-1331.2006.01493.x.

[30] V. J. Quagliarello and W. M. Scheld, “Treatment of Bacterial Meningitis,”

New England Journal of Medicine, vol. 336, no. 10, pp. 708–716, Mar. 1997,

doi: 10.1056/NEJM199703063361007.

[31] V. Quagliarello and W. M. Scheld, “Bacterial Meningitis: Pathogenesis,

Pathophysiology, and Progress,” New England Journal of Medicine, vol. 327,

no. 12, pp. 864–872, Sep. 1992, doi: 10.1056/NEJM199209173271208.

[32] M. C. Brouwer, A. R. Tunkel, and D. van de Beek, “Epidemiology,

diagnosis, and antimicrobial treatment of acute bacterial meningitis,”

Clinical Microbiology Reviews, vol. 23, no. 3, pp. 467–492, 2010, doi:

10.1128/CMR.00070-09.

[33] K. R. Ratzan, “Viral Meningitis,” Medical Clinics of North America, vol. 69,

no. 2, pp. 399–413, 1985, doi: https://doi.org/10.1016/S0025-7125(16)31051-

3.

[34] D. R. Chadwick, “Viral meningitis,” British Medical Bulletin, vol. 75–76, no.

1, pp. 1–14, 2005, doi: 10.1093/bmb/ldh057.

[35] S. A. E. Logan and E. MacMahon, “Viral meningitis,” BMJ, vol. 336, no.

7634, pp. 36 LP – 40, Jan. 2008, doi: 10.1136/bmj.39409.673657.AE.

[36] F. Yetkin, U. Kayabas, Y. Ersoy, Y. Bayindir, S. A. Toplu, and I. Tek,

“Cerebrospinal fluid viscosity: A novel diagnostic measure for acute

meningitis,” Southern Medical Journal, vol. 103, no. 9, pp. 892–895, 2010,

doi: 10.1097/SMJ.0b013e3181ebe260.

113
Miranda-Martínez

[37] J. M. Porcel, M. Azzopardi, C. F. Koegelenberg, F. Maldonado, N. M.

Rahman, and Y. C. G. Lee, “The diagnosis of pleural effusions,” Expert

Review of Respiratory Medicine, vol. 9, no. 6, pp. 801–815, 2015.

[38] B. B. H. Sayed labiba. Ibraheem Dwidar, Eman Raid, “The diagnostic

utility of pleural fluid viscosity in lymphocytic pleural effusion.,”

Egyptian Journal of Bronchology, vol. 6, no. 1, pp. 73–78, 2015, doi:

10.4103/1687-8426.153656.

[39] R. W. Light, M. I. Macgregor, P. C. Luchsinger, and W. C. BALL JR,

“Pleural effusions: the diagnostic separation of transudates and

exudates,” Ann Intern Med, vol. 77, no. 4, pp. 507–513, 1972.

[40] R. W. Light, “The Light criteria: the beginning and why they are useful 40

years later,” Clin Chest Med, vol. 34, no. 1, pp. 21–26, 2013.

[41] K. L. Eibenberger, W. I. Dock, M. E. Ammann, R. Dorffner, M. F.

Hörmann, and F. Grabenwöger, “Quantification of pleural effusions:

sonography versus radiography.,” Radiology, vol. 191, no. 3, pp. 681–684,

1994.

[42] O. Yetkin, I. Tek, A. Kaya, A. Ciledag, and N. Numanoglu, “A simple

laboratory measurement for discrimination of transudative and exudative

pleural effusion: Pleural viscosity,” Respiratory Medicine, vol. 100, no. 7,

pp. 1286–1290, 2006, doi: 10.1016/j.rmed.2005.10.010.

[43] J. M. Alonso, J. A. del Olmo, R. P. Gonzalez, and V. Saez‐martinez,

“Injectable hydrogels: From laboratory to industrialization,” Polymers

(Basel), vol. 13, no. 4, pp. 1–24, 2021, doi: 10.3390/polym13040650.

[44] S. Moeinzadeh and E. Jabbari, “Gelation characteristics, physico-

mechanical properties and degradation kinetics of micellar hydrogels,”

114
References

European Polymer Journal, vol. 72, pp. 566–576, 2015, doi:

10.1016/j.eurpolymj.2015.04.028.

[45] Y. M. Chung, K. L. Simmons, A. Gutowska, and B. Jeong, “Sol-Gel

transition temperature of PLGA-g-PEG aqueous solutions,”

Biomacromolecules, vol. 3, no. 3, pp. 511–516, 2002, doi: 10.1021/bm0156431.

[46] S. van Vlierberghe, P. Dubruel, and E. Schacht, “Biopolymer-Based

Hydrogels As Scaffolds for Tissue Engineering Applications: A Review,”

Biomacromolecules, vol. 12, no. 5, pp. 1387–1408, May 2011, doi:

10.1021/bm200083n.

[47] J.-A. Yang, J. Yeom, B. W. Hwang, A. S. Hoffman, and S. K. Hahn, “In

situ-forming injectable hydrogels for regenerative medicine,” Progress in

Polymer Science, vol. 39, no. 12, pp. 1973–1986, 2014.

[48] P. C. D. P. Dingal and D. E. Discher, “Material control of stem cell

differentiation: challenges in nano-characterization,” Current Opinion in

Biotechnology, vol. 28, pp. 46–50, 2014, doi:

https://doi.org/10.1016/j.copbio.2013.11.003.

[49] Y. Zhao et al., “Hydrogels bearing bioengineered mimetic embryonic

microenvironments for tumor reversion,” Journal of Materials Chemistry B,

vol. 4, no. 37, pp. 6183–6191, 2016, doi: 10.1039/C6TB00927A.

[50] C. Ehre et al., “Overexpressing mouse model demonstrates the protective

role of Muc5ac in the lungs,” Proceedings of the National Academy of

Sciences, vol. 109, no. 41, pp. 16528 LP – 16533, Oct. 2012, doi:

10.1073/pnas.1206552109.

[51] Y. H. Sheng et al., “The MUC13 cell-surface mucin protects against

intestinal inflammation by inhibiting epithelial cell apoptosis,” Gut, vol.

60, no. 12, pp. 1661 LP – 1670, Dec. 2011, doi: 10.1136/gut.2011.239194.

115
Miranda-Martínez

[52] N. Becher, K. A. Waldorf, M. Hein, and N. Uldbjerg, “The cervical mucus

plug: Structured review of the literature,” Acta Obstetricia et Gynecologica

Scandinavica, vol. 88, no. 5, pp. 502–513, Jan. 2009, doi:

10.1080/00016340902852898.

[53] H. Yan et al., “Immune-Informed Mucin Hydrogels Evade Fibrotic

Foreign Body Response In Vivo,” Advanced Functional Materials, vol. 29,

no. 46, p. 1902581, Nov. 2019, doi: https://doi.org/10.1002/adfm.201902581.

[54] H. Yan et al., “Immune-Modulating Mucin Hydrogel Microdroplets for

the Encapsulation of Cell and Microtissue,” Advanced Functional Materials,

vol. 2105967, 2021, doi: 10.1002/adfm.202105967.

[55] A. S. Hoffman, “Hydrogels for biomedical applications,” Advanced Drug

Delivery Reviews, vol. 64, pp. 18–23, 2012, doi:

https://doi.org/10.1016/j.addr.2012.09.010.

[56] H. Alizadeh Sardroud, S. Nemati, A. Baradar Khoshfetrat, M. Nabavinia,

and Y. Beygi Khosrowshahi, “Barium-cross-linked alginate-gelatine

microcapsule as a potential platform for stem cell production and

modular tissue formation,” Journal of Microencapsulation, vol. 34, no. 5, pp.

488–497, 2017, doi: 10.1080/02652048.2017.1354940.

[57] K. Deligkaris, T. S. Tadele, W. Olthuis, and A. van den Berg, “Hydrogel-

based devices for biomedical applications,” Sensors and Actuators, B:

Chemical, vol. 147, no. 2, pp. 765–774, 2010, doi: 10.1016/j.snb.2010.03.083.

[58] F. Boccafoschi, N. Rajan, J. Habermehl, and D. Mantovani, “Preparation

and characterization of a scaffold for vascular tissue engineering by

direct‐assembling of collagen and cells in a cylindrical geometry,”

Macromol Biosci, vol. 7, no. 5, pp. 719–726, 2007.

116
References

[59] L. Xiang and W. Cui, “Biomedical application of photo-crosslinked

gelatin hydrogels,” Journal of Leather Science and Engineering, vol. 3, no. 1,

p. 3, 2021, doi: 10.1186/s42825-020-00043-y.

[60] G. M. Cavallini, L. Campi, G. Delvecchio, A. Lazzerini, and L. Longanesi,

“Comparison of the clinical performance of Healon 5 and Healon in

phacoemulsification,” Eur J Ophthalmol, vol. 12, no. 3, pp. 205–211, 2002.

[61] M. Grellier et al., “The effect of the co-immobilization of human

osteoprogenitors and endothelial cells within alginate microspheres on

mineralization in a bone defect,” Biomaterials, vol. 30, no. 19, pp. 3271–

3278, 2009, doi: https://doi.org/10.1016/j.biomaterials.2009.02.033.

[62] S. v Murphy, A. Skardal, and A. Atala, “Evaluation of hydrogels for

bio‐printing applications,” Journal of Biomedical Materials Research Part A,

vol. 101, no. 1, pp. 272–284, 2013.

[63] M. M. Stanton, J. Samitier, and S. Sanchez, “Bioprinting of 3D hydrogels,”

Lab on a Chip, vol. 15, no. 15, pp. 3111–3115, 2015.

[64] B. Webb and B. J. Doyle, “Parameter optimization for 3D bioprinting of

hydrogels,” Bioprinting, vol. 8, pp. 8–12, 2017, doi:

https://doi.org/10.1016/j.bprint.2017.09.001.

[65] Y. He, F. Yang, H. Zhao, Q. Gao, B. Xia, and J. Fu, “Research on the

printability of hydrogels in 3D bioprinting,” Scientific Reports, vol. 6, no. 1,

p. 29977, 2016, doi: 10.1038/srep29977.

[66] M. B. Łabowska, K. Cierluk, A. M. Jankowska, J. Kulbacka, J. Detyna, and

I. Michalak, “A review on the adaption of alginate-gelatin hydrogels for

3D cultures and bioprinting,” Materials, vol. 14, no. 4, pp. 1–28, 2021, doi:

10.3390/ma14040858.

117
Miranda-Martínez

[67] G. Petrou and T. Crouzier, “Mucins as multifunctional building blocks of

biomaterials,” Biomaterials Science, vol. 6, no. 9, pp. 2282–2297, 2018, doi:

10.1039/C8BM00471D.

[68] L.-C. CHANG, C.-C. HUA, Y.-C. LIU, C.-M. CHU, H.-J. CHEN, and N.

LEE, “Pleural fluid viscosity may help identifying malignant pleural

effusions,” Respirology, vol. 13, no. 3, pp. 341–345, May 2008, doi:

https://doi.org/10.1111/j.1440-1843.2008.01276.x.

[69] O. Yetkin, I. Tek, F. Yetkin, and N. Numanoglu, “Role of pleural viscosity

in the differential diagnosis of exudative pleural effusion,” Respirology,

vol. 12, no. 2, pp. 267–271, 2007.

[70] G. Késmárky, P. Kenyeres, M. Rábai, and K. Tóth, “Plasma viscosity: A

forgotten variable,” Clinical Hemorheology and Microcirculation, vol. 39, no.

1–4, pp. 243–246, 2008, doi: 10.3233/CH-2008-1088.

[71] D. S. Viswanath, T. K. Ghosh, D. H. L. Prasad, N. V. K. Dutt, and K. Y.

Rani, “VISCOMETERS BT - Viscosity of Liquids: Theory, Estimation,

Experiment, and Data,” D. S. Viswanath, T. K. Ghosh, D. H. L. Prasad, N.

V. K. Dutt, and K. Y. Rani, Eds. Dordrecht: Springer Netherlands, 2007,

pp. 9–107. doi: 10.1007/978-1-4020-5482-2_2.

[72] L. Bradshaw, “Understanding piezoelectric quartz crystals,” RF time and

frequency, vol. 8, pp. 50–58, 2000.

[73] M. Rodahl, F. Höök, and B. Kasemo, “QCM operation in liquids: An

explanation of measured variations in frequency and Q factor with liquid

conductivity,” Analytical Chemistry, vol. 68, no. 13, pp. 2219–2227, 1996.

[74] J. A. Balasingam, S. Swaminathan, H. Nazemi, C. Love, Y. Birjis, and A. B.

T.-R. M. in B. S. Emadi, “Chemical Sensors: Gas Sensors, Acoustic

118
References

Sensors,” Elsevier, 2021. doi: https://doi.org/10.1016/B978-0-12-822548-

6.00001-7.

[75] T. Nakamoto and T. Moriizumi, “A Theory of a Quartz Crystal

Microbalance Based upon a Mason Equivalent Circuit,” Japanese Journal of

Applied Physics, vol. 29, no. Part 1, No. 5, pp. 963–969, 1990, doi:

10.1143/jjap.29.963.

[76] S. Na Songkhla and T. Nakamoto, “Interpretation of Quartz Crystal

Microbalance Behavior with Viscous Film Using a Mason Equivalent

Circuit,” Chemosensors , vol. 9, no. 1. 2021. doi:

10.3390/chemosensors9010009.

[77] S. J. Martin, V. E. Granstaff, and G. C. Frye, “Characterization of a Quartz

Crystal Microbalance with Simultaneous Mass and Liquid Loading,”

Analytical Chemistry, vol. 63, no. 20, pp. 2272–2281, 1991, doi:

10.1021/ac00020a015.

[78] J. L. Casteleiro-Roca, J. L. Calvo-Rolle, M. C. Meizoso-Lopez, A. Piñón-

Pazos, and B. A. Rodríguez-Gómez, “New approach for the QCM sensors

characterization,” Sensors and Actuators, A: Physical, vol. 207, pp. 1–9, 2014,

doi: 10.1016/j.sna.2013.12.002.

[79] A. Alassi, M. Benammar, and D. Brett, “Quartz crystal microbalance

electronic interfacing systems: A review,” Sensors (Switzerland), vol. 17,

no. 12, pp. 1–41, 2017, doi: 10.3390/s17122799.

[80] S. N. Songkhla and T. Nakamoto, “Signal Processing of Vector Network

Analyzer Measurement for Quartz Crystal Microbalance With Viscous

Damping,” IEEE Sensors Journal, vol. 19, no. 22, pp. 10386–10392, 2019,

doi: 10.1109/JSEN.2019.2930733.

119
Miranda-Martínez

[81] V. Ferrari, D. Marioli, and A. Taroni, “ACC oscillator for in-liquid quartz

microbalance sensors,” in SENSORS, 2003 IEEE, 2003, vol. 2, pp. 849–854.

[82] W. P. Mason and H. Baerwald, “Piezoelectric crystals and their

applications to ultrasonics,” Physics Today, vol. 4, no. 5, p. 23, 1951.

[83] M. Cassiède, J. L. Daridon, J. H. Paillol, and J. Pauly, “Characterization of

the behaviour of a quartz crystal resonator fully immersed in a

Newtonian liquid by impedance analysis,” Sensors and Actuators, A:

Physical, vol. 167, no. 2, pp. 317–326, 2011, doi: 10.1016/j.sna.2011.03.002.

[84] D. Johannsmann, “Viscoelastic, mechanical, and dielectric measurements

on complex samples with the quartz crystal microbalance,” Physical

Chemistry Chemical Physics, vol. 10, no. 31, pp. 4516–4534, 2008, doi:

10.1039/b803960g.

[85] D. C. Ash, M. J. Joyce, C. Barnes, C. J. Booth, and A. C. Jefferies, “Viscosity

measurement of industrial oils using the droplet quartz crystal

microbalance,” Measurement Science and Technology, vol. 14, no. 11, pp.

1955–1962, 2003, doi: 10.1088/0957-0233/14/11/013.

[86] A. M. Cao-Paz, L. Rodríguez-Pardo, J. Fariña, and J. Marcos-Acevedo,

“Resolution in QCM sensors for the viscosity and density of liquids:

Application to lead acid batteries,” Sensors (Switzerland), vol. 12, no. 8, pp.

10604–10620, 2012, doi: 10.3390/s120810604.

[87] A. Saluja and D. S. Kalonia, “Measurement of fluid viscosity at microliter

volumes using quartz impedance analysis,” Aaps Pharmscitech, vol. 5, no.

3, pp. 68–81, 2004.

120
References

[88] R. Nayak, L. C. Jain, and B. K. H. Ting, “Artificial neural networks in

biomedical engineering: a review,” Computational Mechanics–New Frontiers

for the New Millennium, pp. 887–892, 2001.

[89] J. M. Haglin, G. Jimenez, and A. E. M. Eltorai, “Artificial neural networks

in medicine,” Health and Technology, vol. 9, no. 1, pp. 1–6, 2019.

[90] Y. Mohan, S. S. Chee, D. K. P. Xin, and L. P. Foong, “Artificial neural

network for classification of depressive and normal in EEG,” in 2016 IEEE

EMBS conference on biomedical engineering and sciences (IECBES), 2016, pp.

286–290.

[91] E. O. Olaniyi, O. K. Oyedotun, A. Helwan, and K. Adnan, “Neural

network diagnosis of heart disease,” in 2015 International Conference on

Advances in Biomedical Engineering (ICABME), 2015, pp. 21–24.

[92] L. A. C. Ahumada, M. X. R. González, O. L. H. Sandoval, and J. J. S.

Olmedo, “Evaluation of hyaluronic acid dilutions at different

concentrations using a quartz crystal resonator (QCR) for the potential

diagnosis of arthritic diseases,” Sensors (Switzerland), vol. 16, no. 11, 2016,

doi: 10.3390/s16111959.

[93] L. A. Carvajal Ahumada, N. Peña Pérez, O. L. Herrera Sandoval, F. del

Pozo Guerrero, and J. J. Serrano Olmedo, “A new way to find dielectric

properties of liquid sample using the quartz crystal resonator (QCR),”

Sensors and Actuators A: Physical, vol. 239, pp. 153–160, 2016, doi:

https://doi.org/10.1016/j.sna.2016.01.021.

[94] L. A. Carvajal-Ahumada, “DISEÑO Y EVALUACIÓN DE UN

BIOSENSOR BASADO EN RESONADORES DE CRISTAL DE CUARZO

(QCR) PARA CARACTERIZAR MUESTRAS BIOLÓGICAS

RELACIONADAS CON ENFERMEDADES ARTRÍTICAS,” 2017.

121
Miranda-Martínez

[95] C. Mista, M. Zalazar, A. Pealva, M. Martina, and J. M. Reta, “Open Source

Quartz Crystal Microbalance with dissipation monitoring,” Journal of

Physics: Conference Series, vol. 705, no. 1, 2016, doi: 10.1088/1742-

6596/705/1/012008.

[96] M. Saini and K. K. Sadhu, “Two instantaneous fluorogenic steps for

detection of nanomolar amyloid beta monomer and its interaction with

stoichiometric copper(II) ion,” Sensors and Actuators B: Chemical, vol. 303,

p. 127086, 2020, doi: https://doi.org/10.1016/j.snb.2019.127086.

[97] J. B. Rudell, A. J. Rechs, T. J. Kelman, C. M. Ross-Inta, S. Hao, and D. W.

Gietzen, “The Anterior Piriform Cortex Is Sufficient for Detecting

Depletion of an Indispensable Amino Acid, Showing Independent

Cortical Sensory Function,” The Journal of Neuroscience, vol. 31, no. 5, pp.

1583 LP – 1590, Feb. 2011, doi: 10.1523/JNEUROSCI.4934-10.2011.

[98] R. M. Reguera, “Interpretación del líquido cefalorraquídeo,” Anales de

Pediatria Continuada, vol. 12, no. 1, pp. 30–33, Jan. 2014, doi: 10.1016/S1696-

2818(14)70164-7.

[99] M. G. Codina, M. de Cueto, D. Vicente, J. E. Echevarría, and G. Prats,

“Diagnóstico microbiológico de las infecciones del sistema nervioso

central,” Enfermedades Infecciosas y Microbiología Clínica, vol. 29, no. 2, pp.

127–134, Feb. 2011, doi: 10.1016/j.eimc.2010.10.003.

[100] A. Swan, H. Amer, and P. Dieppe, “The value of synovial fluid assays in

the diagnosis of joint disease: a literature survey,” Annals of the Rheumatic

Diseases, vol. 61, no. 6, pp. 493 LP – 498, Jun. 2002, doi:

10.1136/ard.61.6.493.

122
References

[101] O. Sangha, “Epidemiology of rheumatic diseases,” Rheumatology, vol. 39,

no. suppl_2, pp. 3–12, Dec. 2000, doi: 10.1093/rheumatology/39.suppl_2.3.

[102] M. Talebi-Taher, F. Shirani, N. Nikanjam, and M. Shekarabi, “Septic

versus inflammatory arthritis: discriminating the ability of serum

inflammatory markers,” Rheumatology International, vol. 33, no. 2, pp. 319–

324, 2013, doi: 10.1007/s00296-012-2363-y.

[103] A. C. K. Bierhalz, M. A. da Silva, M. E. M. Braga, H. J. C. Sousa, and T. G.

Kieckbusch, “Effect of calcium and/or barium crosslinking on the physical

and antimicrobial properties of natamycin-loaded alginate films,” LWT -

Food Science and Technology, vol. 57, no. 2, pp. 494–501, 2014, doi:

https://doi.org/10.1016/j.lwt.2014.02.021.

[104] P. Vanysek, “Ionic conductivity and diffusion at infinite dilution,” CRC

hand book of chemistry and physics, pp. 5–92, 1993.

123

También podría gustarte